Pathophysiology - Pulmonary, Cardio, and Hematologic Topics (Vocabulary Flashcards)

Pulmonary Pathology

  • Signs and Symptoms of Pulmonary Disease

    • Dyspnea: subjective sensation of uncomfortable breathing

    • Orthopnea: dyspnea when a person is lying down

  • Abnormal Breathing Patterns

    • Tachypnea: rapid breathing; typically faster than 20 breaths/min

    • Hyperventilation: increased rate and depth of respiration (hyperpnea)

    • Bradypnea: slower than 12 breaths/min

    • Hypoventilation: inadequate ventilation leading to elevated CO₂

    • Apnea: temporary cessation of breathing

    • Kussmaul respirations: rapid, deep, labored breathing

    • Cheyne–Stokes respirations: alternating periods of deep and shallow breathing with apnea

    • Biot (ataxic) breathing: irregular pattern with varying depth and pauses

  • Normal breathing reference

    • Regular and comfortable at a rate of 12−20 breaths/min12-20\ \text{breaths/min}

    • Air trapping and other patterns may reflect specific pathophysiology

  • Signs: hypercapnia, hypoxemia, cyanosis, clubbing, and pulmonary edema

  • Hypercapnia vs Hypocapnia

    • Hypercapnia: elevated arterial CO₂ partial pressure (PaCO₂)

    • Hypocapnia: reduced PaCO₂ (e.g., with hyperventilation)

  • Pulmonary Edema (fluid in lungs)

    • Gas exchange impairment due to excess fluid in interstitium/alveoli

    • Starling forces: pressures governing fluid movement

    • Key fluid movement schema (net filtration):

    • Filtration driven by capillary hydrostatic pressure vs interstitial hydrostatic pressure

    • Reabsorption driven by capillary oncotic pressure vs interstitial oncotic pressure

    • Lymphatics remove excess interstitial fluid

    • Diagrammatic/physiologic summary (simplified):

    • Capillary hydrostatic pressure (Pc) promotes filtration

    • Interstitial hydrostatic pressure (Pi) opposes filtration

    • Capillary oncotic pressure (pi_c) promotes reabsorption

    • Interstitial oncotic pressure (pi_i) promotes filtration

  • Atelectasis (collapse of lung tissue)

    • Absorption atelectasis: inspired air washes out by obstruction (e.g., mucus plug, closed pore of Kohn)

    • Compression atelectasis: external pressure (e.g., tumor) leads to collapse

    • Normal alveolus vs atelectatic alveolus: decreased inflation due to mucus plug or loss of air

  • Bronchiolitis and Bronchiolitis Obliterans

    • Bronchiolitis: inflammatory obstruction of small airways; common in children (RSV); can occur in adults with chronic bronchitis, viral infection, or inhalation of toxic gases

    • Bronchiolitis obliterans (Popcorn lung): late-stage fibrotic disease of airways from chronic inflammation; may occur with bronchiolitis, lung transplant, toxic exposures

  • Pleural Abnormalities

    • Pneumothorax: air in pleural space causing lung collapse

    • Open pneumothorax vs tension pneumothorax (one-way valve effect)

    • Pleural effusion: fluid in pleural space

    • Transudative effusion: due to hydrostatic/oncotic imbalance

    • Exudative effusion: due to inflammation/infection

    • Empyema: pus in pleural space

    • Hemothorax: blood in pleural space

  • Pneumothorax and Pleura visuals (descriptive)

    • Pneumothorax: outside air enters due to disruption of chest wall/parietal pleura or disruption of visceral pleura

    • . Tension pneumothorax: air entry with trapped air increases intrathoracic pressure, compressing mediastinum

  • Smoking effects on lungs

    • Smoking decreases surfactant production, increasing risk of alveolar collapse and impaired compliance

  • Inhalation Disorders

    • Pneumoconiosis (e.g., silica, asbestos, coal) and exposure to toxic gases

    • Allergic alveolitis (hypersensitivity pneumonitis)

  • ARDS (Acute Respiratory Distress Syndrome)

    • Acute lung inflammation with diffuse alveolocapillary injury

    • Bilateral infiltrates on imaging; hypoxemia with decreased PaO₂/FiO₂ ratio

    • Common ICU complication with high mortality; causes include pneumonia, burns, aspiration, pancreatitis, transfusions, inhalation injury, sepsis/DIC

  • Pulmonary infections

    • Pneumonia: alveolar inflammation; community-acquired (e.g., Streptococcus pneumoniae), hospital-acquired pneumonia

    • Pneumococcal pneumonia with lobar involvement (e.g., right upper lobe)

    • Tuberculosis: Mycobacterium tuberculosis; airborne transmission; tubercle formation; positive PPD test

  • Pulmonary Embolism

    • Occlusion of pulmonary arterial bed by thrombus or other embolus; commonly arises from deep veins in the legs

  • Pulmonary Hypertension-related disorders

    • Pulmonary heart disease: right ventricular enlargement/failure due to chronic pulmonary hypertension

  • Obstructive Lung Diseases

    • Asthma, Emphysema, Chronic Bronchitis as common obstructive disorders

  • Chronic Obstructive Pulmonary Diseases (COPD) phenotypes

    • Chronic bronchitis (blue bloater): chronic productive cough >3 months/year for 2 consecutive years; hypoxia, hypercapnia, polycythemia, cyanosis, digital clubbing; right heart failure risk

    • Emphysema (pink puffer): hyperinflation, CO₂ retention with less hypoxemia, pursed-lip breathing, dyspnea, barrel-shaped chest, and thin appearance

  • Pneumonia and related conditions

    • Pneumonia types: community-acquired (S. pneumoniae), nosocomial, viral

    • Lobar pneumonia examples and imaging

  • Key terms and connections

    • ARDS as a form of acute lung injury with alveolocapillary damage

    • Smoking and surfactant impairment contributing to COPD progression

    • Airway obstruction patterns in asthma and COPD

/

Cardio Pathology

  • Cardio Anatomy (major structures)

    • Heart chambers: right atrium, right ventricle, left atrium, left ventricle

    • Valves: tricuspid, mitral (AV valves); pulmonic and aortic (semilunar valves)

    • Major vessels: superior/inferior vena cava, aorta, pulmonary arteries/veins

    • Conduction system: SA node (pacemaker), AV node, Bundle of His, right/left bundle branches, Purkinje fibers

    • Coronary arteries: right coronary artery, left coronary artery with LAD and circumflex branches; collateral arteries

    • Pericardium: parietal and visceral layers, pericardial cavity with fluid; myocardium; endocardium

  • Cardio Physiology basics

    • Cardiac cycle: diastole vs systole

    • Valves and pressure changes during cycle

    • Mean arterial pressure (MAP) and cardiac output (CO) relationships

  • Cardiac Cycle & Pressures

    • Normal intracardiac pressures (mean and range):

    • Right atrium: mean 0-4 mmHg (typical mean ~4 mmHg) with range 0-8

    • Right ventricle: systolic ~24 mmHg (range 15-28); end-diastolic ~4 mmHg (0-8)

    • Left atrium: mean ~7 mmHg (range 4-12)

    • Left ventricle: systolic ~130 mmHg (range 90-140); end-diastolic ~7 mmHg (4-12)

  • Blood Pressure and Hemodynamics

    • BP = CO × PR (peripheral resistance)

    • Cardiac Output (CO) = Heart Rate (HR) × Stroke Volume (SV)

    • Regulation of BP involves: Autonomic nervous system (sympathetic/parasympathetic), baroreceptors, hormonal/humoral factors, local autoregulation (vasodilators/constrictors)

    • Factors affecting blood flow: pressure, resistance (vessel diameter/length), velocity, laminar vs turbulent flow, vascular compliance

    • Neural control centers: hypothalamus influences medullary centers; sympathetic vs vagal (parasympathetic) input to vessels and the heart

  • Cardiac Control and Autonomic Regulation

    • Sympathetic stimulation increases heart rate and contractility; vasoconstriction in arterioles (alpha) and vasodilation in skeletal muscle arterioles (beta midpoint)

    • Parasympathetic activity via the vagus nerve reduces heart rate

  • Cardiac Output determinants

    • Preload: LV end-diastolic volume (venous return)

    • Afterload: ventricular afterload to move blood (aortic pressure)

    • Contractility: inotropic state of the myocardium

    • End-diastolic volume and venous return influence preload; sympathetic activity affects contractility and afterload

  • Conduction System Anatomy and ECG basics

    • Sinoatrial (SA) node as pacemaker; atrioventricular (AV) node; Bundle of His; right/left bundle branches; Purkinje fibers

    • Electrocardiogram (ECG) components: P wave (atrial depolarization), QRS complex (ventricular depolarization), T wave (ventricular repolarization)

    • Intervals: PR interval, QRS duration, QT interval

    • Normal ECG expectations and rate calculations (Lead II common for rate)

  • Heart Sounds

    • S1: closure of atrioventricular valves (tricuspid/mitral) at start of systole

    • S2: closure of semilunar valves (aortic/pulmonic) at end of systole

    • LUB DUB sequence

  • Cardiac Pathology: Pressure–Volume relationships and disease processes

    • Coronary artery disease (CAD): leading cause of myocardial infarction; atherosclerosis is primary etiologic factor

    • Angioplasty and stent placement; coronary artery bypass grafting (CABG) options (single, double, triple, quadruple grafts)

    • Aortic aneurysms: dilation/arrest differences; etiologies include atherosclerosis, HTN, congenital conditions; risk of dissection

    • Disorders of the pericardium: acute pericarditis, constrictive pericarditis, pericardial effusion, tamponade

    • Disorders of the myocardium: dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy

    • Valvular dysfunctions: stenosis, regurgitation; mitral valve prolapse

    • Rheumatic heart disease: post-streptococcal immune-mediated valvular disease

    • Endocarditis: infection/inflammation of endocardium, often affecting valves; vegetations

    • Arrhythmias: tachycardia, bradycardia, flutter, fibrillation, PACs, PVCs, asystole

    • Heart failure: left-sided (systolic vs diastolic), right-sided; systemic venous congestion, pulmonary edema

    • Shock: cardiogenic, hypovolemic, neurogenic, anaphylactic, septic

  • Hypertension and Vascular Pathology

    • Hypertension categories: normal, prehypertension, Stage 1 & Stage 2 hypertension, hypertensive crisis

    • Primary (essential) vs secondary hypertension; major risk factors include age, genetics, obesity/diabetes, smoking, hyperlipidemia, sedentary lifestyle

    • Complications: target organ damage in heart, brain, vasculature, kidneys, eyes (often asymptomatic until damage)

    • Orthostatic hypotension: drop in BP on standing due to impaired compensatory mechanisms

  • Vascular Disorders (overview)

    • Peripheral vascular disease (PVD) and peripheral arterial disease (PAD)

    • Arteriosclerosis vs atherosclerosis

    • Atherosclerosis progression: endothelial injury → fatty streak → formation of fibrous plaque → complicated lesion; mural thrombosis may form

    • Thromboangiitis obliterans (Buerger disease): inflammatory, nonatherosclerotic occlusions in small/medium arteries, often in young male smokers; autoimmune component

    • Raynaud phenomenon/disease: vasospastic disorder causing color changes in fingers/toes with cold or stress

    • Arteriosclerosis: thickening/hardening of arterial walls; loss of elasticity

  • Atherosclerosis details and disease progression

    • Damaged endothelium initiates a cascade leading to lipid accumulation and plaque formation

    • Plaques contain lipid pools, fibrous caps, and potential fissures; vulnerability to rupture leads to acute events (MI, stroke)

    • MODIFIABLE risk factors: dyslipidemia, hypertension, smoking, diabetes, obesity/sedentary lifestyle, atherogenic diet

    • NON-MODIFIABLE risk factors: age, gender, ethnicity, heredity

    • Clinical consequences: CAD, CVA, PAD

Hematologic Pathology

  • Blood composition and basic physiology

    • Blood volume: about 6 quarts (≈5.5 L)

    • Plasma: 90% water, 10% solutes; plasma proteins include albumins, globulins, fibrinogen

    • Formed elements: erythrocytes (RBCs), leukocytes (WBCs), thrombocytes (platelets)

    • Erythrocytes: primary oxygen transport; biconcave shape; lifespan ~120 days; produced via erythropoiesis stimulated by erythropoietin

    • Leukocytes: defense against infection; granulocytes (neutrophils, eosinophils, basophils) and agranulocytes (monocytes/macrophages, lymphocytes)

    • Platelets: essential for coagulation; thrombopoietin regulates production; circulate about 10 days

  • Hematopoiesis and bone marrow

    • Hematopoiesis: production of blood cells via mitosis and maturation/differentiation from multipotent pluripotent stem cells

    • Bone marrow: red (active) and yellow forms; major sites include pelvis, vertebrae, cranium, mandible, sternum, ribs, humerus, femur

    • MPS (mononuclear phagocyte system): monocytes/macrophages in tissues that ingest/destroy microbes and debris

    • Erythropoiesis sequence (simplified): pluripotent stem cell → common myeloid stem cell → erythroid progenitors (CFU-Eo, proerythroblast, normoblast, reticulocyte) → erythrocyte; regulated by erythropoietin from kidney

  • Hemoglobin and iron metabolism

    • Hemoglobin: Hb molecule contains heme groups and globin chains; each Hb can carry up to 4 O₂ molecules

    • Heme consists of iron-protoporphyrin complex; adult Hb typically α2β2 with 4 heme groups

    • Iron, vitamins, and minerals required for Hb synthesis: proteins/amino acids; vitamins B12, B6, B2, folic acid, pantothenic acid, niacin; minerals iron and copper

    • RBC turnover and bilirubin formation: aged RBCs phagocytosed by MPS; globin → amino acids; heme → bilirubin sent to liver and excreted in bile

  • Hematologic evaluation and pathologies

    • Anemias: classified by morphology and Hb content using MCV, MCH, MCHC

    • Macrocytic (large cells) - Normochromic or Normocytic: Pernicious anemia (B12 deficiency), Folate deficiency

    • Microcytic - Hypochromic: Iron deficiency anemia, Sideroblastic anemia, Thalassemia

    • Normocytic - Normochromic: Aplastic anemia, Posthemorrhagic, Hemolytic anemia, Sickle cell disease, Anemia of chronic inflammation

    • Pernicious anemia: B12 deficiency due to lack of intrinsic factor; neurologic manifestations possible; treatment with parenteral or high-dose B12

    • Folate deficiency anemia: lack of folate; absorption in small intestine; treatment with folate supplementation

    • Iron deficiency anemia: most common globally; glossitis and brittle nails; microcytic hypochromic anemia

    • Sideroblastic anemia: iron uptake/metabolism defect; ringed sideroblasts in bone marrow

    • Thalassemia: genetic disorder causing abnormal Hb synthesis; often Mediterranean origin; autosomal recessive

    • Sickle cell anemia: autosomal recessive; Hb S causes RBCs to sickle under hypoxia; crisis and vaso-occlusion

    • Polycythemia: overproduction of RBCs; absolute (PV) vs relative (dehydration)

    • Leukocytosis vs Leukopenia: common protective response vs risk of infection when low

    • Infectious mononucleosis: EBV infection; splenic rupture risk

    • Leukemias: ALL, AML, CML, CLL; acute vs chronic forms; Philadelphia chromosome in CML

    • Lymphadenopathy and Lymphomas: Hodgkin lymphoma (RS cells) vs Non-Hodgkin lymphomas

    • Coagulation disorders: vWF deficiency, vitamin K deficiency, liver disease causing broad hemostasis defects

    • Hemophilia A (factor VIII deficiency) and Hemophilia B (factor IX deficiency); X-linked recessive; variable severity

    • Disseminated Intravascular Coagulation (DIC): complex, fatal coagulation and bleeding; endothelial injury; FDP and D-dimer elevated

  • Hemostasis pathophysiology (coagulation cascade)

    • Primary steps of hemostasis:
      1) Vascular spasm (vasoconstriction) to reduce blood loss
      2) Platelet plug formation: adhesion via von Willebrand factor (vWF), activation, degranulation, aggregation, and stabilizing mesh formation
      3) Coagulation: coagulation cascades produce fibrin to form a stable clot
      4) Clot retraction and dissolution: platelets contracturing to pull wound edges; plasminogen activators convert plasmin to dissolve fibrin

    • Platelet activation requires Ca²⁺ and activation pathways (TXA₂, PGI₂ balance, GPIIb/IIIa receptor activation)

    • Coagulation cascades: Intrinsic, Extrinsic, and Common (classical) pathways culminating in the conversion of fibrinogen to fibrin by thrombin

    • Fibrinolysis: plasminogen → plasmin; plasmin degrades fibrin; D-dimers are fibrin degradation products

  • Practical and clinical connections

    • Understanding of hemodynamics (BP, MAP, CO, PR) helps interpret hypertension, shock, and heart failure dynamics

    • Dysfunctions in the coagulation system predispose to bleeding or thrombosis; DIC exemplifies a catastrophic combination of both

    • Knowledge of the conduction system and ECG basics is essential for recognizing arrhythmias and guiding therapy

    • Anemia classifications guide etiologic workup and treatment (iron vs B12/folate deficiency, anemia of chronic inflammation, hemolysis, etc.)

Key Formulas and Values (quick reference)

  • Blood pressure relationship:

    • BP=CO×PRBP = CO \times PR

  • Cardiac output:

    • CO=HR×SVCO = HR \times SV

  • Mean arterial pressure (MAP) approximation:

    • MAP=(2×diastolic)+systolic3MAP = \dfrac{(2 \times \text{diastolic}) + \text{systolic}}{3}

  • Normal respiratory rate (adults): 12≤RR≤20 breaths/min12 \leq\text{RR} \leq 20\ \text{breaths/min}

  • Hemodynamic/pressure relationships in the heart: reference intracardiac pressures (mean/typical ranges):

    • Right atrium: mean ~4 mmHg (range 0-8)

    • Right ventricle: systolic ~24 mmHg (range 15-28); end-diastolic ~4 (0-8)

    • Left atrium: ~7 mmHg (range 4-12)

    • Left ventricle: systolic ~130 mmHg (range 90-140); end-diastolic ~7 (4-12)

  • RBC and Hb basics

    • RBCs carry oxygen via hemoglobin with 4 heme groups per Hb molecule; each Hb can carry up to 4 O₂ molecules

    • RBC lifespan: about 120 days120\ \text{days}

  • Erythropoiesis regulation

    • Erythropoietin (from kidneys) stimulates RBC production in response to hypoxia

Connections to foundational principles

  • Homeostasis: Blood pressure, heart rate, and vascular resistance are tightly coordinated to maintain tissue perfusion; disturbances lead to hypertension, shock, ischemia

  • Gas exchange and acid-base balance: Pulmonary function (edema, atelectasis, ARDS) directly affects oxygenation and CO₂ removal; acid-base disturbances follow

  • Immunology and hematology integration: Leukocytes, lymphoid organs, and the hematopoietic system coordinate defense, immunity, and blood cell production; infections and malignancies disrupt these processes

  • Pathophysiology of chronic disease: Atherosclerosis, hypertension, COPD, and heart failure show how chronic processes (inflammation, remodeling, hypoxia) drive organ dysfunction over time

  • Ethical and practical implications: Early detection, monitoring, and management of chronic diseases impact quality of life, resource utilization, and long-term outcomes; recognizing asymptomatic hypertension or occult anemia is clinically important

Examples and scenarios (hypothetical)

  • A patient with progressive dyspnea, cyanosis, and edema may have congestive heart failure with reduced ejection fraction (systolic HF) or diastolic HF, requiring evaluation of preload/afterload and CO

  • A smoker presenting with chronic cough, dyspnea, wheeze, and barrel-shaped chest may have emphysema (pink puffer), whereas a patient with productive cough, cyanosis, and edema may have chronic bronchitis (blue bloater)

  • A patient with sudden chest pain and shortness of breath could have a pulmonary embolism or tension pneumothorax; quick recognition and management are critical to prevent collapse

  • Anemia workup includes differentiating macrocytic (B12/folate), microcytic (iron deficiency, sideroblastic, thalassemia), and normocytic etiologies to guide treatment

  • DIC represents a catastrophic failure of coagulation control, often in sepsis, where both thrombosis and bleeding occur concurrently; management focuses on treating the underlying cause and supportive care

References to common clinical entities (brief definitions)

  • ARDS: acute lung inflammation with diffuse alveolocapillary injury and hypoxemia despite oxygen therapy

  • COPD: umbrella term for chronic bronchitis and emphysema, leading to airflow limitation that's not fully reversible

  • TB: airborne infection with Mycobacterium tuberculosis; characteristic granulomas (tubercle formation)

  • Endocarditis: infection of the endocardial surface, often involving heart valves, with vegetations

  • Rheumatic heart disease: autoimmune valvular damage following group A streptococcal pharyngitis

  • Hypertension: sustained elevated arterial pressure; major risk factor for heart disease, stroke, kidney disease

  • Lymphomas/leukemias: clonal proliferations of lymphoid or myeloid cells; vary in aggressiveness and treatment approaches

Notes: The content above consolidates concepts from the provided transcript, including definitions, patterns, epidemiology, pathophysiology, and representative examples. where specific figures or slide references appeared (e.g., diagrams illustrating Starling forces, conduction system pathways, or coagulation cascades), I translated the essential ideas into concise, exam-focused bullet points for study efficiency. LaTeX math is used for key formulas as requested.


Pulmonary Anatomy
  • Nasal cavity

  • Pharynx

  • Larynx

  • Trachea

  • Bronchi

  • Bronchioles

  • Alveoli

    • Type I

    • Type II

Pulmonary Pathology

  • Signs and Symptoms of Pulmonary Disease

    • Dyspnea: subjective sensation of uncomfortable breathing

    • Orthopnea: dyspnea when a person is lying down

  • Abnormal Breathing Patterns

    • Tachypnea: rapid breathing; typically faster than 20 breaths/min

    • Hyperventilation: increased rate and depth of respiration (hyperpnea)

    • Bradypnea: slower than 12 breaths/min

    • Hypoventilation: inadequate ventilation leading to elevated CO₂

    • Apnea: temporary cessation of breathing

    • Kussmaul respirations: rapid, deep, labored breathing

    • Cheyne
      Hypocapnia

    • Hypercapnia: elevated arterial CO₂ partial pressure (PaCO₂)

    • Hypocapnia: reduced PaCO₂ (e.g., with hyperventilation)

  • Pulmonary Edema (fluid in lungs)

    • Gas exchange impairment due to excess fluid in interstitium/alveoli

    • Starling forces: pressures governing fluid movement

    • Key fluid movement schema (net filtration):

    • Filtration driven by capillary hydrostatic pressure vs interstitial hydrostatic pressure

    • Reabsorption driven by capillary oncotic pressure vs interstitial oncotic pressure

    • Lymphatics remove excess interstitial fluid

    • Diagrammatic/physiologic summary (simplified):

    • Capillary hydrostatic pressure (Pc) promotes filtration

    • Interstitial hydrostatic pressure (Pi) opposes filtration

    • Capillary oncotic pressure (pi_c) promotes reabsorption

    • Interstitial oncotic pressure (pi_i) promotes filtration

  • Atelectasis (collapse of lung tissue)

    • Absorption atelectasis: inspired air washes out by obstruction (e.g., mucus plug, closed pore of Kohn)

    • Compression atelectasis: external pressure (e.g., tumor) leads to collapse

    • Normal alveolus vs atelectatic alveolus: decreased inflation due to mucus plug or loss of air

  • Bronchiolitis and Bronchiolitis Obliterans

    • Bronchiolitis: inflammatory obstruction of small airways; common in children (RSV); can occur in adults with chronic bronchitis, viral infection, or inhalation of toxic gases

    • Bronchiolitis obliterans (Popcorn lung): late-stage fibrotic disease of airways from chronic inflammation; may occur with bronchiolitis, lung transplant, toxic exposures

  • Pleural Abnormalities

    • Pneumothorax: air in pleural space causing lung collapse

    • Open pneumothorax vs tension pneumothorax (one-way valve effect)

    • Pleural effusion: fluid in pleural space

    • Transudative effusion: due to hydrostatic/oncotic imbalance

    • Exudative effusion: due to inflammation/infection

    • Empyema: pus in pleural space

    • Hemothorax: blood in pleural space

  • Pneumothorax and Pleura visuals (descriptive)

    • Pneumothorax: outside air enters due to disruption of chest wall/parietal pleura or disruption of visceral pleura

    • . Tension pneumothorax: air entry with trapped air increases intrathoracic pressure, compressing mediastinum

  • Smoking effects on lungs

    • Smoking decreases surfactant production, increasing risk of alveolar collapse and impaired compliance

  • Inhalation Disorders

    • Pneumoconiosis (e.g., silica, asbestos, coal) and exposure to toxic gases

    • Allergic alveolitis (hypersensitivity pneumonitis)

  • ARDS (Acute Respiratory Distress Syndrome)

    • Acute lung inflammation with diffuse alveolocapillary injury

    • Bilateral infiltrates on imaging; hypoxemia with decreased PaO₂/FiO₂ ratio

    • Common ICU complication with high mortality; causes include pneumonia, burns, aspiration, pancreatitis, transfusions, inhalation injury, sepsis/DIC

  • Pulmonary infections

    • Pneumonia: alveolar inflammation; community-acquired (e.g., Streptococcus pneumoniae), hospital-acquired pneumonia

    • Pneumococcal pneumonia with lobar involvement (e.g., right upper lobe)

    • Tuberculosis: Mycobacterium tuberculosis; airborne transmission; tubercle formation; positive PPD test

  • Pulmonary Embolism

    • Occlusion of pulmonary arterial bed by thrombus or other embolus; commonly arises from deep veins in the legs

  • Pulmonary Hypertension-related disorders

    • Pulmonary heart disease: right ventricular enlargement/failure due to chronic pulmonary hypertension

  • Obstructive Lung Diseases

    • Asthma, Emphysema, Chronic Bronchitis as common obstructive disorders

  • Chronic Obstructive Pulmonary Diseases (COPD) phenotypes

    • Chronic bronchitis (blue bloater): chronic productive cough >3 months/year for 2 consecutive years; hypoxia, hypercapnia, polycythemia, cyanosis, digital clubbing; right heart failure risk

    • Emphysema (pink puffer): hyperinflation, CO₂ retention with less hypoxemia, pursed-lip breathing, dyspnea, barrel-shaped chest, and thin appearance

  • Pneumonia and related conditions

    • Pneumonia types: community-acquired (S. pneumoniae), nosocomial, viral

    • Lobar pneumonia examples and imaging

  • Key terms and connections

    • ARDS as a form of acute lung injury with alveolocapillary damage

    • Smoking and surfactant impairment contributing to COPD progression

    • Airway obstruction patterns in asthma and COPD

Cardio Pathology
  • Cardio Anatomy (major structures)

    • Heart chambers: right atrium, right ventricle, left atrium, left ventricle

    • Valves: tricuspid, mitral (AV valves); pulmonic and aortic (semilunar valves)

    • Major vessels: superior/inferior vena cava, aorta, pulmonary arteries/veins

    • Conduction system: SA node (pacemaker), AV node, Bundle of His, right/left bundle branches, Purkinje fibers

    • Coronary arteries: right coronary artery, left coronary artery with LAD and circumflex branches; collateral arteries

    • Pericardium: parietal and visceral layers, pericardial cavity with fluid; myocardium; endocardium

  • Cardio Physiology basics

    • Cardiac cycle: diastole vs systole

    • Valves and pressure changes during cycle

    • Mean arterial pressure (MAP) and cardiac output (CO) relationships

  • Cardiac Cycle & Pressures

    • Normal intracardiac pressures (mean and range):

    • Right atrium: mean 0-4 mmHg (typical mean ~4 mmHg) with range 0-8

    • Right ventricle: systolic ~24 mmHg (range 15-28); end-diastolic ~4 mmHg (0-8)

    • Left atrium: mean ~7 mmHg (range 4-12)

    • Left ventricle: systolic ~130 mmHg (range 90-140); end-diastolic ~7 mmHg (4-12)

  • Blood Pressure and Hemodynamics

    • BP = CO × PR (peripheral resistance)

    • Cardiac Output (CO) = Heart Rate (HR) × Stroke Volume (SV)

    • Regulation of BP involves: Autonomic nervous system (sympathetic/parasympathetic), baroreceptors, hormonal/humoral factors, local autoregulation (vasodilators/constrictors)

    • Factors affecting blood flow: pressure, resistance (vessel diameter/length), velocity, laminar vs turbulent flow, vascular compliance

    • Neural control centers: hypothalamus influences medullary centers; sympathetic vs vagal (parasympathetic) input to vessels and the heart

  • Cardiac Control and Autonomic Regulation

    • Sympathetic stimulation increases heart rate and contractility; vasoconstriction in arterioles (alpha) and vasodilation in skeletal muscle arterioles (beta midpoint)

    • Parasympathetic activity via the vagus nerve reduces heart rate

  • Cardiac Output determinants

    • Preload: LV end-diastolic volume (venous return)

    • Afterload: ventricular afterload to move blood (aortic pressure)

    • Contractility: inotropic state of the myocardium

    • End-diastolic volume and venous return influence preload; sympathetic activity affects contractility and afterload

  • Conduction System Anatomy and ECG basics

    • Sinoatrial (SA) node as pacemaker; atrioventricular (AV) node; Bundle of His; right/left bundle branches; Purkinje fibers

    • Electrocardiogram (ECG) components: P wave (atrial depolarization), QRS complex (ventricular depolarization), T wave (ventricular repolarization)

    • Intervals: PR interval, QRS duration, QT interval

    • Normal ECG expectations and rate calculations (Lead II common for rate)

  • Heart Sounds

    • S1: closure of atrioventricular valves (tricuspid/mitral) at start of systole

    • S2: closure of semilunar valves (aortic/pulmonic) at end of systole

    • LUB DUB sequence

  • Cardiac Pathology: Pressure–Volume relationships and disease processes

    • Coronary artery disease (CAD): leading cause of myocardial infarction; atherosclerosis is primary etiologic factor

    • Angioplasty and stent placement; coronary artery bypass grafting (CABG) options (single, double, triple, quadruple grafts)

    • Aortic aneurysms: dilation/arrest differences; etiologies include atherosclerosis, HTN, congenital conditions; risk of dissection

    • Disorders of the pericardium: acute pericarditis, constrictive pericarditis, pericardial effusion, tamponade

    • Disorders of the myocardium: dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy

    • Valvular dysfunctions: stenosis, regurgitation; mitral valve prolapse

    • Rheumatic heart disease: post-streptococcal immune-mediated valvular disease

    • Endocarditis: infection/inflammation of endocardium, often affecting valves; vegetations

    • Arrhythmias: tachycardia, bradycardia, flutter, fibrillation, PACs, PVCs, asystole

    • Heart failure: left-sided (systolic vs diastolic), right-sided; systemic venous congestion, pulmonary edema

    • Shock: cardiogenic, hypovolemic, neurogenic, anaphylactic, septic

  • Hypertension and Vascular Pathology

    • Hypertension categories: normal, prehypertension, Stage 1 & Stage 2 hypertension, hypertensive crisis

    • Primary (essential) vs secondary hypertension; major risk factors include age, genetics, obesity/diabetes, smoking, hyperlipidemia, sedentary lifestyle

    • Complications: target organ damage in heart, brain, vasculature, kidneys, eyes (often asymptomatic until damage)

    • Orthostatic hypotension: drop in BP on standing due to impaired compensatory mechanisms

  • Vascular Disorders (overview)

    • Peripheral vascular disease (PVD) and peripheral arterial disease (PAD)

    • Arteriosclerosis vs atherosclerosis

    • Atherosclerosis progression: endothelial injury → fatty streak → formation of fibrous plaque → complicated lesion; mural thrombosis may form

    • Thromboangiitis obliterans (Buerger disease): inflammatory, nonatherosclerotic occlusions in small/medium arteries, often in young male smokers; autoimmune component

    • Raynaud phenomenon/disease: vasospastic disorder causing color changes in fingers/toes with cold or stress

    • Arteriosclerosis: thickening/hardening of arterial walls; loss of elasticity

  • Atherosclerosis details and disease progression

    • Damaged endothelium initiates a cascade leading to lipid accumulation and plaque formation

    • Plaques contain lipid pools, fibrous caps, and potential fissures; vulnerability to rupture leads to acute events (MI, stroke)

    • MODIFIABLE risk factors: dyslipidemia, hypertension, smoking, diabetes, obesity/sedentary lifestyle, atherogenic diet

    • NON-MODIFIABLE risk factors: age, gender, ethnicity, heredity

    • Clinical consequences: CAD, CVA, PAD

Hematologic Pathology
  • Blood composition and basic physiology

    • Blood volume: about 6 quarts (≈5.5 L)

    • Plasma: 90% water, 10% solutes; plasma proteins include albumins, globulins, fibrinogen

    • Formed elements: erythrocytes (RBCs), leukocytes (WBCs), thrombocytes (platelets)

    • Erythrocytes: primary oxygen transport; biconcave shape; lifespan ~120 days; produced via erythropoiesis stimulated by erythropoietin

    • Leukocytes: defense against infection; granulocytes (neutrophils, eosinophils, basophils) and agranulocytes (monocytes/macrophages, lymphocytes)

    • Platelets: essential for coagulation; thrombopoietin regulates production; circulate about 10 days

  • Hematopoiesis and bone marrow

    • Hematopoiesis: production of blood cells via mitosis and maturation/differentiation from multipotent pluripotent stem cells

    • Bone marrow: red (active) and yellow forms; major sites include pelvis, vertebrae, cranium, mandible, sternum, ribs, humerus, femur

    • MPS (mononuclear phagocyte system): monocytes/macrophages in tissues that ingest/destroy microbes and debris

    • Erythropoiesis sequence (simplified): pluripotent stem cell → common myeloid stem cell → erythroid progenitors (CFU-Eo, proerythroblast, normoblast, reticulocyte) → erythrocyte; regulated by erythropoietin from kidney

  • Hemoglobin and iron metabolism

    • Hemoglobin: Hb molecule contains heme groups and globin chains; each Hb can carry up to 4 O₂ molecules

    • Heme consists of iron-protoporphyrin complex; adult Hb typically α2β2 with 4 heme groups

    • Iron, vitamins, and minerals required for Hb synthesis: proteins/amino acids; vitamins B12, B6, B2, folic acid, pantothenic acid, niacin; minerals iron and copper

    • RBC turnover and bilirubin formation: aged RBCs phagocytosed by MPS; globin → amino acids; heme → bilirubin sent to liver and excreted in bile

  • Hematologic evaluation and pathologies

    • Anemias: classified by morphology and Hb content using MCV, MCH, MCHC

    • Macrocytic (large cells) - Normochromic or Normocytic: Pernicious anemia (B12 deficiency), Folate deficiency

    • Microcytic - Hypochromic: Iron deficiency anemia, Sideroblastic anemia, Thalassemia

    • Normocytic - Normochromic: Aplastic anemia, Posthemorrhagic, Hemolytic anemia, Sickle cell disease, Anemia of chronic inflammation

    • Pernicious anemia: B12 deficiency due to lack of intrinsic factor; neurologic manifestations possible; treatment with parenteral or high-dose B12

    • Folate deficiency anemia: lack of folate; absorption in small intestine; treatment with folate supplementation

    • Iron deficiency anemia: most common globally; glossitis and brittle nails; microcytic hypochromic anemia

    • Sideroblastic anemia: iron uptake/metabolism defect; ringed sideroblasts in bone marrow

    • Thalassemia: genetic disorder causing abnormal Hb synthesis; often Mediterranean origin; autosomal recessive

    • Sickle cell anemia: autosomal recessive; Hb S causes RBCs to sickle under hypoxia; crisis and vaso-occlusion

    • Polycythemia: overproduction of RBCs; absolute (PV) vs relative (dehydration)

    • Leukocytosis vs Leukopenia: common protective response vs risk of infection when low

    • Infectious mononucleosis: EBV infection; splenic rupture risk

    • Leukemias: ALL, AML, CML, CLL; acute vs chronic forms; Philadelphia chromosome in CML

    • Lymphadenopathy and Lymphomas: Hodgkin lymphoma (RS cells) vs Non-Hodgkin lymphomas

    • Coagulation disorders: vWF deficiency, vitamin K deficiency, liver disease causing broad hemostasis defects

    • Hemophilia A (factor VIII deficiency) and Hemophilia B (factor IX deficiency); X-linked recessive; variable severity

    • Disseminated Intravascular Coagulation (DIC): complex, fatal coagulation and bleeding; endothelial injury; FDP and D-dimer elevated

  • Hemostasis pathophysiology (coagulation cascade)

    • Primary steps of hemostasis:

      1) Vascular spasm (vasoconstriction) to reduce blood loss

      2) Platelet plug formation: adhesion via von Willebrand factor (vWF), activation, degranulation, aggregation, and stabilizing mesh formation

      3) Coagulation: coagulation cascades produce fibrin to form a stable clot

      4) Clot retraction and dissolution: platelets contracturing to pull wound edges; plasminogen activators convert plasmin to dissolve fibrin

    • Platelet activation requires Ca²⁺ and activation pathways (TXA₂, PGI₂ balance, GPIIb/IIIa receptor activation)

    • Coagulation cascades: Intrinsic, Extrinsic, and Common (classical) pathways culminating in the conversion of fibrinogen to fibrin by thrombin

    • Fibrinolysis: plasminogen → plasmin; plasmin degrades fibrin; D-dimers are fibrin degradation products

  • Practical and clinical connections

    • Understanding of hemodynamics (BP, MAP, CO, PR) helps interpret hypertension, shock, and heart failure dynamics

    • Dysfunctions in the coagulation system predispose to bleeding or thrombosis; DIC exemplifies a catastrophic combination of both

    • Knowledge of the conduction system and ECG basics is essential for recognizing arrhythmias and guiding therapy

    • Anemia classifications guide etiologic workup and treatment (iron vs B12/folate deficiency, anemia of chronic inflammation, hemolysis, etc.)

Key Formulas and Values (quick reference)
  • Blood pressure relationship:

    • BP=CO×PRBP = CO \times PR

  • Cardiac output:

    • CO=HR×SVCO = HR \times SV

  • Mean arterial pressure (MAP) approximation:

    • MAP=(2×diastolic)+systolic3MAP = \dfrac{(2 \times \text{diastolic}) + \text{systolic}}{3}

  • Normal respiratory rate (adults): 12≤RR≤20 breaths/min12 \leq\text{RR} \leq 20\ \text{breaths/min}

  • Hemodynamic/pressure relationships in the heart: reference intracardiac pressures (mean/typical ranges):

    • Right atrium: mean ~4 mmHg (range 0-8)

    • Right ventricle: systolic ~24 mmHg (range 15-28); end-diastolic ~4 (0-8)

    • Left atrium: ~7 mmHg (range 4-12)

    • Left ventricle: systolic ~130 mmHg (range 90-140); end-diastolic ~7 (4-12)

  • RBC and Hb basics

    • RBCs carry oxygen via hemoglobin with 4 heme groups per Hb molecule; each Hb can carry up to 4 O₂ molecules

    • RBC lifespan: about 120 days120\ \text{days}

  • Erythropoiesis regulation

    • Erythropoietin (from kidneys) stimulates RBC production in response to hypoxia

Connections to foundational principles
  • Homeostasis: Blood pressure, heart rate, and vascular resistance are tightly coordinated to maintain tissue perfusion; disturbances lead to hypertension, shock, ischemia

  • Gas exchange and acid-base balance: Pulmonary function (edema, atelectasis, ARDS) directly affects oxygenation and CO₂ removal; acid-base disturbances follow

  • Immunology and hematology integration: Leukocytes, lymphoid organs, and the hematopoietic system coordinate defense, immunity, and blood cell production; infections and malignancies disrupt these processes

  • Pathophysiology of chronic disease: Atherosclerosis, hypertension, COPD, and heart failure show how chronic processes (inflammation, remodeling, hypoxia) drive organ dysfunction over time

  • Ethical and practical implications: Early detection, monitoring, and management of chronic diseases impact quality of life, resource utilization, and long-term outcomes; recognizing asymptomatic hypertension or occult anemia is clinically important

Examples and scenarios (hypothetical)
  • A patient with progressive dyspnea, cyanosis, and edema may have congestive heart failure with reduced ejection fraction (systolic HF) or diastolic HF, requiring evaluation of preload/afterload and CO

  • A smoker presenting with chronic cough, dyspnea, wheeze, and barrel-shaped chest may have emphysema (pink puffer), whereas a patient with productive cough, cyanosis, and edema may have chronic bronchitis (blue bloater)

  • A patient with sudden chest pain and shortness of breath could have a pulmonary embolism or tension pneumothorax; quick recognition and management are critical to prevent collapse

  • Anemia workup includes differentiating macrocytic (B12/folate), microcytic (iron deficiency, sideroblastic, thalassemia), and normocytic etiologies to guide treatment

  • DIC represents a catastrophic failure of coagulation control, often in sepsis, where both thrombosis and bleeding occur concurrently; management focuses on treating the underlying cause and supportive care

References to common clinical entities (brief definitions)
  • ARDS: acute lung inflammation with diffuse alveolocapillary injury and hypoxemia despite oxygen therapy

  • COPD: umbrella term for chronic bronchitis and emphysema, leading to airflow limitation that's not fully reversible

  • TB: airborne infection with Mycobacterium tuberculosis; characteristic granulomas (tubercle formation)

  • Endocarditis: infection of the endocardial surface, often involving heart valves, with vegetations

  • Rheumatic heart disease: autoimmune valvular damage following group A streptococcal pharyngitis

  • Hypertension: sustained elevated arterial pressure; major risk factor for heart disease, stroke, kidney disease

  • Lymphomas/leukemias: clonal proliferations of lymphoid or myeloid cells; vary in aggressiveness and treatment approaches


Pulmonary Pathology

Pulmonary Anatomy

  • Nasal cavity

  • Pharynx

  • Larynx

  • Trachea

  • Bronchi

  • Bronchioles

  • Alveoli

    • Type I

    • Type II

  • Lungs

  • Pleura/Serous Membrane

Pulmonary Physiology

Pressures

  • Law of gases

  • PA (Alveolar Pressure)

  • PB (Barometric Pressure)

  • PIP (Intrapleural Pressure)

  • Inspiration versus expiration

Muscles of breathing

  • Inspiration

  • Expiration

  • Forced expiration

  • Signs and Symptoms of Pulmonary Disease

    • Dyspnea: subjective sensation of uncomfortable breathing

    • Orthopnea: dyspnea when a person is lying down


  • Abnormal Breathing Patterns

    • Tachypnea: rapid breathing; typically faster than 20 breaths/min

    • Hyperventilation: increased rate and depth of respiration (hyperpnea)

    • Bradypnea: slower than 12 breaths/min

    • Hypoventilation: inadequate ventilation leading to elevated CO₂

    • Apnea: temporary cessation of breathing

    • Kussmaul respirations: rapid, deep, labored breathing

    • Cheyne–Stokes respirations: alternating periods of deep and shallow breathing with apnea

    • Biot (ataxic) breathing: irregular pattern with varying depth and pauses


  • Normal breathing reference

    • Regular and comfortable at a rate of 12−20 breaths/min12-20\ \text{breaths/min}

    • Air trapping and other patterns may reflect specific pathophysiology


  • Signs: hypercapnia, hypoxemia, cyanosis, clubbing, and pulmonary edema

  • Hypercapnia vs Hypocapnia

    • Hypercapnia: elevated arterial CO₂ partial pressure (PaCO₂)

    • Hypocapnia: reduced PaCO₂ (e.g., with hyperventilation)


  • Pulmonary Edema (fluid in lungs)

    • Gas exchange impairment due to excess fluid in interstitium/alveoli

    • Starling forces: pressures governing fluid movement

    • Key fluid movement schema (net filtration):

    • Filtration driven by capillary hydrostatic pressure vs interstitial hydrostatic pressure

    • Reabsorption driven by capillary oncotic pressure vs interstitial oncotic pressure

    • Lymphatics remove excess interstitial fluid

    • Diagrammatic/physiologic summary (simplified):

    • Capillary hydrostatic pressure (Pc) promotes filtration

    • Interstitial hydrostatic pressure (Pi) opposes filtration

    • Capillary oncotic pressure (pi_c) promotes reabsorption

    • Interstitial oncotic pressure (pi_i) promotes filtration


  • Atelectasis (collapse of lung tissue)

    • Absorption atelectasis: inspired air washes out by obstruction (e.g., mucus plug, closed pore of Kohn)

    • Compression atelectasis: external pressure (e.g., tumor) leads to collapse

    • Normal alveolus vs atelectatic alveolus: decreased inflation due to mucus plug or loss of air


  • Bronchiolitis and Bronchiolitis Obliterans

    • Bronchiolitis: inflammatory obstruction of small airways; common in children (RSV); can occur in adults with chronic bronchitis, viral infection, or inhalation of toxic gases

    • Bronchiolitis obliterans (Popcorn lung): late-stage fibrotic disease of airways from chronic inflammation; may occur with bronchiolitis, lung transplant, toxic exposures


  • Pleural Abnormalities

    • Pneumothorax: air in pleural space causing lung collapse

    • Open pneumothorax vs tension pneumothorax (one-way valve effect)

    • Pleural effusion: fluid in pleural space

    • Transudative effusion: due to hydrostatic/oncotic imbalance

    • Exudative effusion: due to inflammation/infection

    • Empyema: pus in pleural space

    • Hemothorax: blood in pleural space


  • Pneumothorax and Pleura visuals (descriptive)

    • Pneumothorax: outside air enters due to disruption of chest wall/parietal pleura or disruption of visceral pleura

    • . Tension pneumothorax: air entry with trapped air increases intrathoracic pressure, compressing mediastinum


  • Smoking effects on lungs

    • Smoking decreases surfactant production, increasing risk of alveolar collapse and impaired compliance


  • Inhalation Disorders

    • Pneumoconiosis (e.g., silica, asbestos, coal) and exposure to toxic gases

    • Allergic alveolitis (hypersensitivity pneumonitis)


  • ARDS (Acute Respiratory Distress Syndrome)

    • Acute lung inflammation with diffuse alveolocapillary injury

    • Bilateral infiltrates on imaging; hypoxemia with decreased PaO₂/FiO₂ ratio

    • Common ICU complication with high mortality; causes include pneumonia, burns, aspiration, pancreatitis, transfusions, inhalation injury, sepsis/DIC


  • Pulmonary infections

    • Pneumonia: alveolar inflammation; community-acquired (e.g., Streptococcus pneumoniae), hospital-acquired pneumonia

    • Pneumococcal pneumonia with lobar involvement (e.g., right upper lobe)

    • Tuberculosis: Mycobacterium tuberculosis; airborne transmission; tubercle formation; positive PPD test


  • Pulmonary Embolism

    • Occlusion of pulmonary arterial bed by thrombus or other embolus; commonly arises from deep veins in the legs


  • Pulmonary Hypertension-related disorders

    • Pulmonary heart disease: right ventricular enlargement/failure due to chronic pulmonary hypertension


  • Obstructive Lung Diseases

    • Asthma, Emphysema, Chronic Bronchitis as common obstructive disorders


  • Chronic Obstructive Pulmonary Diseases (COPD) phenotypes

    • Chronic bronchitis (blue bloater): chronic productive cough >3 months/year for 2 consecutive years; hypoxia, hypercapnia, polycythemia, cyanosis, digital clubbing; right heart failure risk

    • Emphysema (pink puffer): hyperinflation, CO₂ retention with less hypoxemia, pursed-lip breathing, dyspnea, barrel-shaped chest, and thin appearance


  • Pneumonia and related conditions

    • Pneumonia types: community-acquired (S. pneumoniae), nosocomial, viral

    • Lobar pneumonia examples and imaging


  • Key terms and connections

    • ARDS as a form of acute lung injury with alveolocapillary damage

    • Smoking and surfactant impairment contributing to COPD progression

    • Airway obstruction patterns in asthma and COPD

Cardio Pathology
  • Cardio Anatomy (major structures)

    • Heart chambers: right atrium, right ventricle, left atrium, left ventricle

    • Valves: tricuspid, mitral (AV valves); pulmonic and aortic (semilunar valves)

    • Major vessels: superior/inferior vena cava, aorta, pulmonary arteries/veins

    • Conduction system: SA node (pacemaker), AV node, Bundle of His, right/left bundle branches, Purkinje fibers

    • Coronary arteries: right coronary artery, left coronary artery with LAD and circumflex branches; collateral arteries

    • Pericardium: parietal and visceral layers, pericardial cavity with fluid; myocardium; endocardium


  • Cardio Physiology basics

    • Cardiac cycle: diastole vs systole

    • Valves and pressure changes during cycle

    • Mean arterial pressure (MAP) and cardiac output (CO) relationships


  • Cardiac Cycle & Pressures

    • Normal intracardiac pressures (mean and range):

    • Right atrium: mean 0-4 mmHg (typical mean ~4 mmHg) with range 0-8

    • Right ventricle: systolic ~24 mmHg (range 15-28); end-diastolic ~4 mmHg (0-8)

    • Left atrium: mean ~7 mmHg (range 4-12)

    • Left ventricle: systolic ~130 mmHg (range 90-140); end-diastolic ~7 mmHg (4-12)


  • Blood Pressure and Hemodynamics

    • BP = CO × PR (peripheral resistance)

    • Cardiac Output (CO) = Heart Rate (HR) × Stroke Volume (SV)

    • Regulation of BP involves: Autonomic nervous system (sympathetic/parasympathetic), baroreceptors, hormonal/humoral factors, local autoregulation (vasodilators/constrictors)

    • Factors affecting blood flow: pressure, resistance (vessel diameter/length), velocity, laminar vs turbulent flow, vascular compliance

    • Neural control centers: hypothalamus influences medullary centers; sympathetic vs vagal (parasympathetic) input to vessels and the heart


  • Cardiac Control and Autonomic Regulation

    • Sympathetic stimulation increases heart rate and contractility; vasoconstriction in arterioles (alpha) and vasodilation in skeletal muscle arterioles (beta midpoint)

    • Parasympathetic activity via the vagus nerve reduces heart rate


  • Cardiac Output determinants

    • Preload: LV end-diastolic volume (venous return)

    • Afterload: ventricular afterload to move blood (aortic pressure)

    • Contractility: inotropic state of the myocardium

    • End-diastolic volume and venous return influence preload; sympathetic activity affects contractility and afterload


  • Conduction System Anatomy and ECG basics

    • Sinoatrial (SA) node as pacemaker; atrioventricular (AV) node; Bundle of His; right/left bundle branches; Purkinje fibers

    • Electrocardiogram (ECG) components: P wave (atrial depolarization), QRS complex (ventricular depolarization), T wave (ventricular repolarization)

    • Intervals: PR interval, QRS duration, QT interval

    • Normal ECG expectations and rate calculations (Lead II common for rate)


  • Heart Sounds

    • S1: closure of atrioventricular valves (tricuspid/mitral) at start of systole

    • S2: closure of semilunar valves (aortic/pulmonic) at end of systole

    • LUB DUB sequence


  • Cardiac Pathology: Pressure–Volume relationships and disease processes

    • Coronary artery disease (CAD): leading cause of myocardial infarction; atherosclerosis is primary etiologic factor

    • Angioplasty and stent placement; coronary artery bypass grafting (CABG) options (single, double, triple, quadruple grafts)

    • Aortic aneurysms: dilation/arrest differences; etiologies include atherosclerosis, HTN, congenital conditions; risk of dissection

    • Disorders of the pericardium: acute pericarditis, constrictive pericarditis, pericardial effusion, tamponade

    • Disorders of the myocardium: dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy

    • Valvular dysfunctions: stenosis, regurgitation; mitral valve prolapse

    • Rheumatic heart disease: post-streptococcal immune-mediated valvular disease

    • Endocarditis: infection/inflammation of endocardium, often affecting valves; vegetations

    • Arrhythmias: tachycardia, bradycardia, flutter, fibrillation, PACs, PVCs, asystole

    • Heart failure: left-sided (systolic vs diastolic), right-sided; systemic venous congestion, pulmonary edema

    • Shock: cardiogenic, hypovolemic, neurogenic, anaphylactic, septic


  • Hypertension and Vascular Pathology

    • Hypertension categories: normal, prehypertension, Stage 1 & Stage 2 hypertension, hypertensive crisis

    • Primary (essential) vs secondary hypertension; major risk factors include age, genetics, obesity/diabetes, smoking, hyperlipidemia, sedentary lifestyle

    • Complications: target organ damage in heart, brain, vasculature, kidneys, eyes (often asymptomatic until damage)

    • Orthostatic hypotension: drop in BP on standing due to impaired compensatory mechanisms


  • Vascular Disorders (overview)

    • Peripheral vascular disease (PVD) and peripheral arterial disease (PAD)

    • Arteriosclerosis vs atherosclerosis

    • Atherosclerosis progression: endothelial injury → fatty streak → formation of fibrous plaque → complicated lesion; mural thrombosis may form

    • Thromboangiitis obliterans (Buerger disease): inflammatory, nonatherosclerotic occlusions in small/medium arteries, often in young male smokers; autoimmune component

    • Raynaud phenomenon/disease: vasospastic disorder causing color changes in fingers/toes with cold or stress

    • Arteriosclerosis: thickening/hardening of arterial walls; loss of elasticity


  • Atherosclerosis details and disease progression

    • Damaged endothelium initiates a cascade leading to lipid accumulation and plaque formation

    • Plaques contain lipid pools, fibrous caps, and potential fissures; vulnerability to rupture leads to acute events (MI, stroke)

    • MODIFIABLE risk factors: dyslipidemia, hypertension, smoking, diabetes, obesity/sedentary lifestyle, atherogenic diet

    • NON-MODIFIABLE risk factors: age, gender, ethnicity, heredity

    • Clinical consequences: CAD, CVA, PAD

Hematologic Pathology
  • Blood composition and basic physiology

    • Blood volume: about 6 quarts (≈5.5 L)

    • Plasma: 90% water, 10% solutes; plasma proteins include albumins, globulins, fibrinogen

    • Formed elements: erythrocytes (RBCs), leukocytes (WBCs), thrombocytes (platelets)

    • Erythrocytes: primary oxygen transport; biconcave shape; lifespan ~120 days; produced via erythropoiesis stimulated by erythropoietin

    • Leukocytes: defense against infection; granulocytes (neutrophils, eosinophils, basophils) and agranulocytes (monocytes/macrophages, lymphocytes)

    • Platelets: essential for coagulation; thrombopoietin regulates production; circulate about 10 days


  • Hematopoiesis and bone marrow

    • Hematopoiesis: production of blood cells via mitosis and maturation/differentiation from multipotent pluripotent stem cells

    • Bone marrow: red (active) and yellow forms; major sites include pelvis, vertebrae, cranium, mandible, sternum, ribs, humerus, femur

    • MPS (mononuclear phagocyte system): monocytes/macrophages in tissues that ingest/destroy microbes and debris

    • Erythropoiesis sequence (simplified): pluripotent stem cell → common myeloid stem cell → erythroid progenitors (CFU-Eo, proerythroblast, normoblast, reticulocyte) → erythrocyte; regulated by erythropoietin from kidney


  • Hemoglobin and iron metabolism

    • Hemoglobin: Hb molecule contains heme groups and globin chains; each Hb can carry up to 4 O₂ molecules

    • Heme consists of iron-protoporphyrin complex; adult Hb typically α2β2 with 4 heme groups

    • Iron, vitamins, and minerals required for Hb synthesis: proteins/amino acids; vitamins B12, B6, B2, folic acid, pantothenic acid, niacin; minerals iron and copper

    • RBC turnover and bilirubin formation: aged RBCs phagocytosed by MPS; globin → amino acids; heme → bilirubin sent to liver and excreted in bile


  • Hematologic evaluation and pathologies

    • Anemias: classified by morphology and Hb content using MCV, MCH, MCHC

    • Macrocytic (large cells) - Normochromic or Normocytic: Pernicious anemia (B12 deficiency), Folate deficiency

    • Microcytic - Hypochromic: Iron deficiency anemia, Sideroblastic anemia, Thalassemia

    • Normocytic - Normochromic: Aplastic anemia, Posthemorrhagic, Hemolytic anemia, Sickle cell disease, Anemia of chronic inflammation

    • Pernicious anemia: B12 deficiency due to lack of intrinsic factor; neurologic manifestations possible; treatment with parenteral or high-dose B12

    • Folate deficiency anemia: lack of folate; absorption in small intestine; treatment with folate supplementation

    • Iron deficiency anemia: most common globally; glossitis and brittle nails; microcytic hypochromic anemia

    • Sideroblastic anemia: iron uptake/metabolism defect; ringed sideroblasts in bone marrow

    • Thalassemia: genetic disorder causing abnormal Hb synthesis; often Mediterranean origin; autosomal recessive

    • Sickle cell anemia: autosomal recessive; Hb S causes RBCs to sickle under hypoxia; crisis and vaso-occlusion

    • Polycythemia: overproduction of RBCs; absolute (PV) vs relative (dehydration)

    • Leukocytosis vs Leukopenia: common protective response vs risk of infection when low

    • Infectious mononucleosis: EBV infection; splenic rupture risk

    • Leukemias: ALL, AML, CML, CLL; acute vs chronic forms; Philadelphia chromosome in CML

    • Lymphadenopathy and Lymphomas: Hodgkin lymphoma (RS cells) vs Non-Hodgkin lymphomas

    • Coagulation disorders: vWF deficiency, vitamin K deficiency, liver disease causing broad hemostasis defects

    • Hemophilia A (factor VIII deficiency) and Hemophilia B (factor IX deficiency); X-linked recessive; variable severity

    • Disseminated Intravascular Coagulation (DIC): complex, fatal coagulation and bleeding; endothelial injury; FDP and D-dimer elevated


  • Hemostasis pathophysiology (coagulation cascade)

    • Primary steps of hemostasis:

      1) Vascular spasm (vasoconstriction) to reduce blood loss

      2) Platelet plug formation: adhesion via von Willebrand factor (vWF), activation, degranulation, aggregation, and stabilizing mesh formation

      3) Coagulation: coagulation cascades produce fibrin to form a stable clot

      4) Clot retraction and dissolution: platelets contracturing to pull wound edges; plasminogen activators convert plasmin to dissolve fibrin

    • Platelet activation requires Ca²⁺ and activation pathways (TXA₂, PGI₂ balance, GPIIb/IIIa receptor activation)

    • Coagulation cascades: Intrinsic, Extrinsic, and Common (classical) pathways culminating in the conversion of fibrinogen to fibrin by thrombin

    • Fibrinolysis: plasminogen → plasmin; plasmin degrades fibrin; D-dimers are fibrin degradation products


  • Practical and clinical connections

    • Understanding of hemodynamics (BP, MAP, CO, PR) helps interpret hypertension, shock, and heart failure dynamics

    • Dysfunctions in the coagulation system predispose to bleeding or thrombosis; DIC exemplifies a catastrophic combination of both

    • Knowledge of the conduction system and ECG basics is essential for recognizing arrhythmias and guiding therapy

    • Anemia classifications guide etiologic workup and treatment (iron vs B12/folate deficiency, anemia of chronic inflammation, hemolysis, etc.)

Key Formulas and Values (quick reference)
  • Blood pressure relationship:

    • BP=CO×PRBP = CO \times PR


  • Cardiac output:

    • CO=HR×SVCO = HR \times SV


  • Mean arterial pressure (MAP) approximation:

    • MAP=(2×diastolic)+systolic3MAP = \dfrac{(2 \times \text{diastolic}) + \text{systolic}}{3}


  • Normal respiratory rate (adults): 12≤RR≤20 breaths/min12 \leq\text{RR} \leq 20\ \text{breaths/min}

  • Hemodynamic/pressure relationships in the heart: reference intracardiac pressures (mean/typical ranges):

    • Right atrium: mean ~4 mmHg (range 0-8)

    • Right ventricle: systolic ~24 mmHg (range 15-28); end-diastolic ~4 (0-8)

    • Left atrium: ~7 mmHg (range 4-12)

    • Left ventricle: systolic ~130 mmHg (range 90-140); end-diastolic ~7 (4-12)


  • RBC and Hb basics

    • RBCs carry oxygen via hemoglobin with 4 heme groups per Hb molecule; each Hb can carry up to 4 O₂ molecules

    • RBC lifespan: about 120 days120\ \text{days}


  • Erythropoiesis regulation

    • Erythropoietin (from kidneys) stimulates RBC production in response to hypoxia

Connections to foundational principles
  • Homeostasis: Blood pressure, heart rate, and vascular resistance are tightly coordinated to maintain tissue perfusion; disturbances lead to hypertension, shock, ischemia

  • Gas exchange and acid-base balance: Pulmonary function (edema, atelectasis, ARDS) directly affects oxygenation and CO₂ removal; acid-base disturbances follow

  • Immunology and hematology integration: Leukocytes, lymphoid organs, and the hematopoietic system coordinate defense, immunity, and blood cell production; infections and malignancies disrupt these processes

  • Pathophysiology of chronic disease: Atherosclerosis, hypertension, COPD, and heart failure show how chronic processes (inflammation, remodeling, hypoxia) drive organ dysfunction over time

  • Ethical and practical implications: Early detection, monitoring, and management of chronic diseases impact quality of life, resource utilization, and long-term outcomes; recognizing asymptomatic hypertension or occult anemia is clinically important

Examples and scenarios (hypothetical)
  • A patient with progressive dyspnea, cyanosis, and edema may have congestive heart failure with reduced ejection fraction (systolic HF) or diastolic HF, requiring evaluation of preload/afterload and CO

  • A smoker presenting with chronic cough, dyspnea, wheeze, and barrel-shaped chest may have emphysema (pink puffer), whereas a patient with productive cough, cyanosis, and edema may have chronic bronchitis (blue bloater)

  • A patient with sudden chest pain and shortness of breath could have a pulmonary embolism or tension pneumothorax; quick recognition and management are critical to prevent collapse

  • Anemia workup includes differentiating macrocytic (B12/folate), microcytic (iron deficiency, sideroblastic, thalassemia), and normocytic etiologies to guide treatment

  • DIC represents a catastrophic failure of coagulation control, often in sepsis, where both thrombosis and bleeding occur concurrently; management focuses on treating the underlying cause and supportive care

References to common clinical entities (brief definitions)
  • ARDS: acute lung inflammation with diffuse alveolocapillary injury and hypoxemia despite oxygen therapy

  • COPD: umbrella term for chronic bronchitis and emphysema, leading to airflow limitation that's not fully reversible

  • TB: airborne infection with Mycobacterium tuberculosis; characteristic granulomas (tubercle formation)

  • Endocarditis: infection of the endocardial surface, often involving heart valves, with vegetations

  • Rheumatic heart disease: autoimmune valvular damage following group A streptococcal pharyngitis

  • Hypertension: sustained elevated arterial pressure; major risk factor for heart disease, stroke, kidney disease

  • Lymphomas/leukemias: clonal proliferations of


Pulmonary Pathology
  • Pulmonary Anatomy

    • Nasal cavity

    • Pharynx

    • Larynx

    • Trachea

    • Bronchi

    • Bronchioles

    • Alveoli

      • Type I

      • Type II

    • Lungs

    • Pleura/Serous Membrane

  • Pulmonary Physiology

    • Pressures

      • Law of gases

      • PA (Alveolar Pressure)

      • PB (Barometric Pressure)

      • PIP (Intrapleural Pressure)

      • Inspiration versus expiration

    • Muscles of breathing

      • Inspiration

      • Expiration

      • Forced expiration

    • Surfactant functions

    • Elastic properties

      • Elastic recoil

      • Compliance

      • Resistance

    • Pulmonary functions

      • Ventilation

      • Diffusion

      • Perfusion

    • Gas transport

      • Oxygen transport

      • CO2 transport

    • Ventilation perfusion ratio

      • Shunting

      • Mismatched V/Q ratio

    • Normal breathing reference

      • Regular and comfortable at a rate of 12−20 breaths/min12-20\ \text{breaths/min}

      • Air trapping and other patterns may reflect specific pathophysiology


  • Signs and Symptoms of Pulmonary Disease

    • Dyspnea: subjective sensation of uncomfortable breathing

    • Orthopnea: dyspnea when a person is lying down


  • Abnormal Breathing Patterns

    • Tachypnea: rapid breathing; typically faster than 20 breaths/min

    • Hyperventilation: increased rate and depth of respiration (hyperpnea)

    • Bradypnea: slower than 12 breaths/min

    • Hypoventilation: inadequate ventilation leading to elevated CO₂

    • Apnea: temporary cessation of breathing

    • Kussmaul respirations: rapid, deep, labored breathing

    • Cheyne–Stokes respirations: alternating periods of deep and shallow breathing with apnea

    • Biot (ataxic) breathing: irregular pattern with varying depth and pauses


  • Signs: hypercapnia, hypoxemia, cyanosis, clubbing, and pulmonary edema

  • Hypercapnia vs Hypocapnia

    • Hypercapnia: elevated arterial CO₂ partial pressure (PaCO₂)

    • Hypocapnia: reduced PaCO₂ (e.g., with hyperventilation)


  • Pulmonary Edema (fluid in lungs)

    • Gas exchange impairment due to excess fluid in interstitium/alveoli

    • Starling forces: pressures governing fluid movement

    • Key fluid movement schema (net filtration):

    • Filtration driven by capillary hydrostatic pressure vs interstitial hydrostatic pressure

    • Reabsorption driven by capillary oncotic pressure vs interstitial oncotic pressure

    • Lymphatics remove excess interstitial fluid

    • Diagrammatic/physiologic summary (simplified):

    • Capillary hydrostatic pressure (Pc) promotes filtration

    • Interstitial hydrostatic pressure (Pi) opposes filtration

    • Capillary oncotic pressure (pi_c) promotes reabsorption

    • Interstitial oncotic pressure (pi_i) promotes filtration


  • Atelectasis (collapse of lung tissue)

    • Absorption atelectasis: inspired air washes out by obstruction (e.g., mucus plug, closed pore of Kohn)

    • Compression atelectasis: external pressure (e.g., tumor) leads to collapse

    • Normal alveolus vs atelectatic alveolus: decreased inflation due to mucus plug or loss of air


  • Bronchiolitis and Bronchiolitis Obliterans

    • Bronchiolitis: inflammatory obstruction of small airways; common in children (RSV); can occur in adults with chronic bronchitis, viral infection, or inhalation of toxic gases

    • Bronchiolitis obliterans (Popcorn lung): late-stage fibrotic disease of airways from chronic inflammation; may occur with bronchiolitis, lung transplant, toxic exposures


  • Pleural Abnormalities

    • Pneumothorax: air in pleural space causing lung collapse

    • Open pneumothorax vs tension pneumothorax (one-way valve effect)

    • Pleural effusion: fluid in pleural space

    • Transudative effusion: due to hydrostatic/oncotic imbalance

    • Exudative effusion: due to inflammation/infection

    • Empyema: pus in pleural space

    • Hemothorax: blood in pleural space


  • Pneumothorax and Pleura visuals (descriptive)

    • Pneumothorax: outside air enters due to disruption of chest wall/parietal pleura or disruption of visceral pleura

    • . Tension pneumothorax: air entry with trapped air increases intrathoracic pressure, compressing mediastinum


  • Smoking effects on lungs

    • Smoking decreases surfactant production, increasing risk of alveolar collapse and impaired compliance


  • Inhalation Disorders

    • Pneumoconiosis (e.g., silica, asbestos, coal) and exposure to toxic gases

    • Allergic alveolitis (hypersensitivity pneumonitis)


  • ARDS (Acute Respiratory Distress Syndrome)

    • Acute lung inflammation with diffuse alveolocapillary injury

    • Bilateral infiltrates on imaging; hypoxemia with decreased PaO₂/FiO₂ ratio

    • Common ICU complication with high mortality; causes include pneumonia, burns, aspiration, pancreatitis, transfusions, inhalation injury, sepsis/DIC


  • Pulmonary infections

    • Pneumonia: alveolar inflammation; community-acquired (e.g., Streptococcus pneumoniae), hospital-acquired pneumonia

    • Pneumococcal pneumonia with lobar involvement (e.g., right upper lobe)

    • Tuberculosis: Mycobacterium tuberculosis; airborne transmission; tubercle formation; positive PPD test


  • Pulmonary Embolism

    • Occlusion of pulmonary arterial bed by thrombus or other embolus; commonly arises from deep veins in the legs


  • Pulmonary Hypertension-related disorders

    • Pulmonary heart disease: right ventricular enlargement/failure due to chronic pulmonary hypertension


  • Obstructive Lung Diseases

    • Asthma, Emphysema, Chronic Bronchitis as common obstructive disorders


  • Chronic Obstructive Pulmonary Diseases (COPD) phenotypes

    • Chronic bronchitis (blue bloater): chronic productive cough >3 months/year for 2 consecutive years; hypoxia, hypercapnia, polycythemia, cyanosis, digital clubbing; right heart failure risk

    • Emphysema (pink puffer): hyperinflation, CO₂ retention with less hypoxemia, pursed-lip breathing, dyspnea, barrel-shaped chest, and thin appearance


  • Pneumonia and related conditions

    • Pneumonia types: community-acquired (S. pneumoniae), nosocomial, viral

    • Lobar pneumonia examples and imaging


  • Key terms and connections

    • ARDS as a form of acute lung injury with alveolocapillary damage

    • Smoking and surfactant impairment contributing to COPD progression

    • Airway obstruction patterns in asthma and COPD

Cardio Pathology
  • Cardio Anatomy (major structures)

    • Heart chambers: right atrium, right ventricle, left atrium, left ventricle

    • Valves: tricuspid, mitral (AV valves); pulmonic and aortic (semilunar valves)

    • Major vessels: superior/inferior vena cava, aorta, pulmonary arteries/veins

    • Conduction system: SA node (pacemaker), AV node, Bundle of His, right/left bundle branches, Purkinje fibers

    • Coronary arteries: right coronary artery, left coronary artery with LAD and circumflex branches; collateral arteries

    • Pericardium: parietal and visceral layers, pericardial cavity with fluid; myocardium; endocardium


  • Cardio Physiology basics

    • Cardiac cycle: diastole vs systole

    • Valves and pressure changes during cycle

    • Mean arterial pressure (MAP) and cardiac output (CO) relationships


  • Cardiac Cycle & Pressures

    • Normal intracardiac pressures (mean and range):

    • Right atrium: mean 0-4 mmHg (typical mean ~4 mmHg) with range 0-8

    • Right ventricle: systolic ~24 mmHg (range 15-28); end-diastolic ~4 mmHg (0-8)

    • Left atrium: mean ~7 mmHg (range 4-12)

    • Left ventricle: systolic ~130 mmHg (range 90-140); end-diastolic ~7 mmHg (4-12)


  • Blood Pressure and Hemodynamics

    • BP = CO × PR (peripheral resistance)

    • Cardiac Output (CO) = Heart Rate (HR) × Stroke Volume (SV)

    • Regulation of BP involves: Autonomic nervous system (sympathetic/parasympathetic), baroreceptors, hormonal/humoral factors, local autoregulation (vasodilators/constrictors)

    • Factors affecting blood flow: pressure, resistance (vessel diameter/length), velocity, laminar vs turbulent flow, vascular compliance

    • Neural control centers: hypothalamus influences medullary centers; sympathetic vs vagal (parasympathetic) input to vessels and the heart


  • Cardiac Control and Autonomic Regulation

    • Sympathetic stimulation increases heart rate and contractility; vasoconstriction in arterioles (alpha) and vasodilation in skeletal muscle arterioles (beta midpoint)

    • Parasympathetic activity via the vagus nerve reduces heart rate


  • Cardiac Output determinants

    • Preload: LV end-diastolic volume (venous return)

    • Afterload: ventricular afterload to move blood (aortic pressure)

    • Contractility: inotropic state of the myocardium

    • End-diastolic volume and venous return influence preload; sympathetic activity affects contractility and afterload


  • Conduction System Anatomy and ECG basics

    • Sinoatrial (SA) node as pacemaker; atrioventricular (AV) node; Bundle of His; right/left bundle branches; Purkinje fibers

    • Electrocardiogram (ECG) components: P wave (atrial depolarization), QRS complex (ventricular depolarization), T wave (ventricular repolarization)

    • Intervals: PR interval, QRS duration, QT interval

    • Normal ECG expectations and rate calculations (Lead II common for rate)


  • Heart Sounds

    • S1: closure of atrioventricular valves (tricuspid/mitral) at start of systole

    • S2: closure of semilunar valves (aortic/pulmonic) at end of systole

    • LUB DUB sequence


  • Cardiac Pathology: Pressure–Volume relationships and disease processes

    • Coronary artery disease (CAD): leading cause of myocardial infarction; atherosclerosis is primary etiologic factor

    • Angioplasty and stent placement; coronary artery bypass grafting (CABG) options (single, double, triple, quadruple grafts)

    • Aortic aneurysms: dilation/arrest differences; etiologies include atherosclerosis, HTN, congenital conditions; risk of dissection

    • Disorders of the pericardium: acute pericarditis, constrictive pericarditis, pericardial effusion, tamponade

    • Disorders of the myocardium: dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy

    • Valvular dysfunctions: stenosis, regurgitation; mitral valve prolapse

    • Rheumatic heart disease: post-streptococcal immune-mediated valvular disease

    • Endocarditis: infection/inflammation of endocardium, often affecting valves; vegetations

    • Arrhythmias: tachycardia, bradycardia, flutter, fibrillation, PACs, PVCs, asystole

    • Heart failure: left-sided (systolic vs diastolic), right-sided; systemic venous congestion, pulmonary edema

    • Shock: cardiogenic, hypovolemic, neurogenic, anaphylactic, septic


  • Hypertension and Vascular Pathology

    • Hypertension categories: normal, prehypertension, Stage 1 & Stage 2 hypertension, hypertensive crisis

    • Primary (essential) vs secondary hypertension; major risk factors include age, genetics, obesity/diabetes, smoking, hyperlipidemia, sedentary lifestyle

    • Complications: target organ damage in heart, brain, vasculature, kidneys, eyes (often asymptomatic until damage)

    • Orthostatic hypotension: drop in BP on standing due to impaired compensatory mechanisms


  • Vascular Disorders (overview)

    • Peripheral vascular disease (PVD) and peripheral arterial disease (PAD)

    • Arteriosclerosis vs atherosclerosis

    • Atherosclerosis progression: endothelial injury → fatty streak → formation of fibrous plaque → complicated lesion; mural thrombosis may form

    • Thromboangiitis obliterans (Buerger disease): inflammatory, nonatherosclerotic occlusions in small/medium arteries, often in young male smokers; autoimmune component

    • Raynaud phenomenon/disease: vasospastic disorder causing color changes in fingers/toes with cold or stress

    • Arteriosclerosis: thickening/hardening of arterial walls; loss of elasticity


  • Atherosclerosis details and disease progression

    • Damaged endothelium initiates a cascade leading to lipid accumulation and plaque formation

    • Plaques contain lipid pools, fibrous caps, and potential fissures; vulnerability to rupture leads to acute events (MI, stroke)

    • MODIFIABLE risk factors: dyslipidemia, hypertension, smoking, diabetes, obesity/sedentary lifestyle, atherogenic diet

    • NON-MODIFIABLE risk factors: age, gender, ethnicity, heredity

    • Clinical consequences: CAD, CVA, PAD

Hematologic Pathology
  • Blood composition and basic physiology

    • Blood volume: about 6 quarts (≈5.5 L)

    • Plasma: 90% water, 10% solutes; plasma proteins include albumins, globulins, fibrinogen

    • Formed elements: erythrocytes (RBCs), leukocytes (WBCs), thrombocytes (platelets)

    • Erythrocytes: primary oxygen transport; biconcave shape; lifespan ~120 days; produced via erythropoiesis stimulated by erythropoietin

    • Leukocytes: defense against infection; granulocytes (neutrophils, eosinophils, basophils) and agranulocytes (monocytes/macrophages, lymphocytes)

    • Platelets: essential for coagulation; thrombopoietin regulates production; circulate about 10 days


  • Hematopoiesis and bone marrow

    • Hematopoiesis: production of blood cells via mitosis and maturation/differentiation from multipotent pluripotent stem cells

    • Bone marrow: red (active) and yellow forms; major sites include pelvis, vertebrae, cranium, mandible, sternum, ribs, humerus, femur

    • MPS (mononuclear phagocyte system): monocytes/macrophages in tissues that ingest/destroy microbes and debris

    • Erythropoiesis sequence (simplified): pluripotent stem cell → common myeloid stem cell → erythroid progenitors (CFU-Eo, proerythroblast, normoblast, reticulocyte) → erythrocyte; regulated by erythropoietin from kidney


  • Hemoglobin and iron metabolism

    • Hemoglobin: Hb molecule contains heme groups and globin chains; each Hb can carry up to 4 O₂ molecules

    • Heme consists of iron-protoporphyrin complex; adult Hb typically α2β2 with 4 heme groups

    • Iron, vitamins, and minerals required for Hb synthesis: proteins/amino acids; vitamins B12, B6, B2, folic acid, pantothenic acid, niacin; minerals iron and copper

    • RBC turnover and bilirubin formation: aged RBCs phagocytosed by MPS; globin → amino acids; heme → bilirubin sent to liver and excreted in bile


  • Hematologic evaluation and pathologies

    • Anemias: classified by morphology and Hb content using MCV, MCH, MCHC

    • Macrocytic (large cells) - Normochromic or Normocytic: Pernicious anemia (B12 deficiency), Folate deficiency

    • Microcytic - Hypochromic: Iron deficiency anemia, Sideroblastic anemia, Thalassemia

    • Normocytic - Normochromic: Aplastic anemia, Posthemorrhagic, Hemolytic anemia, Sickle cell disease, Anemia of chronic inflammation

    • Pernicious anemia: B12 deficiency due to lack of intrinsic factor; neurologic manifestations possible; treatment with parenteral or high-dose B12

    • Folate deficiency anemia: lack of folate; absorption in small intestine; treatment with folate supplementation

    • Iron deficiency anemia: most common globally; glossitis and brittle nails; microcytic hypochromic anemia

    • Sideroblastic anemia: iron uptake/metabolism defect; ringed sideroblasts in bone marrow

    • Thalassemia: genetic disorder causing abnormal Hb synthesis; often Mediterranean origin; autosomal recessive

    • Sickle cell anemia: autosomal recessive; Hb S causes RBCs to sickle under hypoxia; crisis and vaso-occlusion

    • Polycythemia: overproduction of RBCs; absolute (PV) vs relative (dehydration)

    • Leukocytosis vs Leukopenia: common protective response vs risk of infection when low

    • Infectious mononucleosis: EBV infection; splenic rupture risk

    • Leukemias: ALL, AML, CML, CLL; acute vs chronic forms; Philadelphia chromosome in CML

    • Lymphadenopathy and Lymphomas: Hodgkin lymphoma (RS cells) vs Non-Hodgkin lymphomas

    • Coagulation disorders: vWF deficiency, vitamin K deficiency, liver disease causing broad hemostasis defects

    • Hemophilia A (factor VIII deficiency) and Hemophilia B (factor IX deficiency); X-linked recessive; variable severity

    • Disseminated Intravascular Coagulation (DIC): complex, fatal coagulation and bleeding; endothelial injury; FDP and D-dimer elevated


  • Hemostasis pathophysiology (coagulation cascade)

    • Primary steps of hemostasis:

      1) Vascular spasm (vasoconstriction) to reduce blood loss

      2) Platelet plug formation: adhesion via von Willebrand factor (vWF), activation, degranulation, aggregation, and stabilizing mesh formation

      3) Coagulation: coagulation cascades produce fibrin to form a stable clot

      4) Clot retraction and dissolution: platelets contracturing to pull wound edges; plasminogen activators convert plasmin to dissolve fibrin

    • Platelet activation requires Ca²⁺ and activation pathways (TXA₂, PGI₂ balance, GPIIb/IIIa receptor activation)

    • Coagulation cascades: Intrinsic, Extrinsic, and Common (classical) pathways culminating in the conversion of fibrinogen to fibrin by thrombin

    • Fibrinolysis: plasminogen → plasmin; plasmin degrades fibrin; D-dimers are fibrin degradation products


  • Practical and clinical connections

    • Understanding of hemodynamics (BP, MAP, CO, PR) helps interpret hypertension, shock, and heart failure dynamics

    • Dysfunctions in the coagulation system predispose to bleeding or thrombosis; DIC exemplifies a catastrophic combination of both

    • Knowledge of the conduction system and ECG basics is essential for recognizing arrhythmias and guiding therapy

    • Anemia classifications guide etiologic workup and treatment (iron vs B12/folate deficiency, anemia of chronic inflammation, hemolysis, etc.)

Key Formulas and Values (quick reference)
  • Blood pressure relationship:

    • BP=CO×PRBP = CO \times PR


  • Cardiac output:

    • CO=HR×SVCO = HR \times SV


  • Mean arterial pressure (MAP) approximation:

    • MAP=(2×diastolic)+systolic3MAP = \dfrac{(2 \times \text{diastolic}) + \text{systolic}}{3}


  • Normal respiratory rate (adults): 12≤RR≤20 breaths/min12 \leq\text{RR} \leq 20\ \text{breaths/min}

  • Hemodynamic/pressure relationships in the heart: reference intracardiac pressures (mean/typical ranges):

    • Right atrium: mean ~4 mmHg (range 0-8)

    • Right ventricle: systolic ~24 mmHg (range 15-28); end-diastolic ~4 (0-8)

    • Left atrium: ~7 mmHg (range 4-12)

    • Left ventricle: systolic ~130 mmHg (range 90-140); end-diastolic ~7 (4-12)


  • RBC and Hb basics

    • RBCs carry oxygen via hemoglobin with 4 heme groups per Hb molecule; each Hb can carry up to 4 O₂ molecules

    • RBC lifespan: about 120 days120\ \text{days}


  • Erythropoiesis regulation

    • Erythropoietin (from kidneys) stimulates RBC production in response to hypoxia

Connections to foundational principles
  • Homeostasis: Blood pressure, heart rate, and vascular resistance are tightly coordinated to maintain tissue perfusion; disturbances lead to hypertension, shock, ischemia

  • Gas exchange and acid-base balance: Pulmonary function (edema, atelectasis, ARDS) directly affects oxygenation and CO₂ removal; acid-base disturbances follow

  • Immunology and hematology integration: Leukocytes, lymphoid organs, and the hematopoietic system coordinate defense, immunity, and blood cell production; infections and malignancies disrupt these processes

  • Pathophysiology of chronic disease: Atherosclerosis, hypertension, COPD, and heart failure show how chronic processes (inflammation, remodeling, hypoxia) drive organ dysfunction over time

  • Ethical and practical implications: Early detection, monitoring, and management of chronic diseases impact quality of life, resource utilization, and long-term outcomes; recognizing asymptomatic hypertension or occult anemia is clinically important

Examples and scenarios (hypothetical)
  • A patient with progressive dyspnea, cyanosis, and edema may have congestive heart failure with reduced ejection fraction (systolic HF) or diastolic HF, requiring evaluation of preload/afterload and CO

  • A smoker presenting with chronic cough, dyspnea, wheeze, and barrel-shaped chest may have emphysema (pink puffer), whereas a patient with productive cough, cyanosis, and edema may have chronic bronchitis (blue bloater)

  • A patient with sudden chest pain and shortness of breath could have a pulmonary embolism or tension pneumothorax; quick recognition and management are critical to prevent collapse

  • Anemia workup includes differentiating macrocytic (B12/folate), microcytic (iron deficiency, sideroblastic, thalassemia), and normocytic etiologies to guide treatment

  • DIC represents a catastrophic failure of coagulation control, often in sepsis, where both thrombosis and bleeding occur concurrently; management focuses on treating the underlying cause and supportive care

References to common clinical entities (brief definitions)
  • ARDS: acute lung inflammation with diffuse alveolocapillary injury and hypoxemia despite oxygen therapy

  • COPD: umbrella term for chronic bronchitis and emphysema, leading to airflow limitation that's not fully reversible

  • TB: airborne infection with Mycobacterium tuberculosis; characteristic granulomas (tubercle formation)

  • Endocarditis: infection of the endocardial surface, often involving heart valves, with vegetations

  • Rheumatic heart disease: autoimmune valvular damage following group A streptococcal pharyngitis

  • Hypertension: sustained elevated arterial pressure; major risk factor for heart disease, stroke, kidney disease

  • Lymphomas/leukemias: clonal proliferations of lymphoid or myeloid cells; vary in aggressiveness and treatment approaches


Pulmonary Pathology
  • Abnormal Breathing Patterns

    • Tachypnea: rapid breathing; typically faster than 20 breaths/min

    • Bradypnea: slower than 12 breaths/min

    • Apnea: temporary cessation of breathing

    • Hyperventilation: increased rate and depth of respiration (hyperpnea)

    • Kussmaul respirations: rapid, deep, labored breathing

    • Hypoventilation: inadequate ventilation leading to elevated CO₂

    • Cheyne–Stokes respirations: alternating periods of deep and shallow breathing with apnea

  • Signs

    • Cyanosis

    • Clubbing

  • Pulmonary Edema (fluid in lungs)

    • Gas exchange impairment due to excess fluid in interstitium/alveoli

    • Starling forces: pressures governing fluid movement

    • Key fluid movement schema (net filtration):

    • Filtration driven by capillary hydrostatic pressure vs interstitial hydrostatic pressure

    • Reabsorption driven by capillary oncotic pressure vs interstitial oncotic pressure

    • Lymphatics remove excess interstitial fluid

    • Diagrammatic/physiologic summary (simplified):

    • Capillary hydrostatic pressure (Pc) promotes filtration

    • Interstitial hydrostatic pressure (Pi) opposes filtration

    • Capillary oncotic pressure (pi_c) promotes reabsorption

    • Interstitial oncotic pressure (pi_i) promotes filtration

  • Atelectasis (collapse of lung tissue)

    • Absorption atelectasis: inspired air washes out by obstruction (e.g., mucus plug, closed pore of Kohn)

    • Compression atelectasis: external pressure (e.g., tumor) leads to collapse

  • Bronchiolitis and Bronchiolitis Obliterans

    • Bronchiolitis: inflammatory obstruction of small airways; common in children (RSV); can occur in adults with chronic bronchitis, viral infection, or inhalation of toxic gases

    • Bronchiolitis obliterans (Popcorn lung): late-stage fibrotic disease of airways from chronic inflammation; may occur with bronchiolitis, lung transplant, toxic exposures

  • Pneumothorax

    • Air in pleural space causing lung collapse

    • Open pneumothorax: disruption of chest wall/parietal pleura or visceral pleura allows outside air entry

    • Tension pneumothorax: one-way valve effect where air entry with trapped air increases intrathoracic pressure, compressing mediastinum


Pulmonary Pathology
  • Abnormal Breathing Patterns

    • Tachypnea: rapid breathing; typically faster than 20 breaths/min

    • Bradypnea: slower than 12 breaths/min

    • Apnea: temporary cessation of breathing

    • Hyperventilation: increased rate and depth of respiration (hyperpnea)

    • Kussmaul respirations: rapid, deep, labored breathing

    • Hypoventilation: inadequate ventilation leading to elevated CO₂

    • Cheyne–Stokes respirations: alternating periods of deep and shallow breathing with apnea

  • Signs

    • Cyanosis

    • Clubbing

  • Pulmonary Edema (fluid in lungs)

    • Gas exchange impairment due to excess fluid in interstitium/alveoli

    • Starling forces: pressures governing fluid movement

    • Key fluid movement schema (net filtration):

    • Filtration driven by capillary hydrostatic pressure vs interstitial hydrostatic pressure

    • Reabsorption driven by capillary oncotic pressure vs interstitial oncotic pressure

    • Lymphatics remove excess interstitial fluid

    • Diagrammatic/physiologic summary (simplified):

    • Capillary hydrostatic pressure (Pc) promotes filtration

    • Interstitial hydrostatic pressure (Pi) opposes filtration

    • Capillary oncotic pressure (pi_c) promotes reabsorption

    • Interstitial oncotic pressure (pi_i) promotes filtration

  • Atelectasis (collapse of lung tissue)

    • Absorption atelectasis: inspired air washes out by obstruction (e.g., mucus plug, closed pore of Kohn)

    • Compression atelectasis: external pressure (e.g., tumor) leads to collapse

  • Bronchiolitis and Bronchiolitis Obliterans

    • Bronchiolitis: inflammatory obstruction of small airways; common in children (RSV); can occur in adults with chronic bronchitis, viral infection, or inhalation of toxic gases

    • Bronchiolitis obliterans (Popcorn lung): late-stage fibrotic disease of airways from chronic inflammation; may occur with bronchiolitis, lung transplant, toxic exposures

  • Pneumothorax

    • Air in pleural space causing lung collapse

    • Open pneumothorax: disruption of chest wall/parietal pleura or visceral pleura allows outside air entry

    • Tension pneumothorax: one-way valve effect where air entry with trapped air increases intrathoracic pressure, compressing mediastinum


Pulmonary Pathology
  • Pulmonary Anatomy

    • Nasal cavity

    • Pharynx

    • Larynx

    • Trachea

    • Bronchi

    • Bronchioles

    • Alveoli

      • Type I

      • Type II

    • Lungs

    • Pleura/Serous Membrane


  • Pulmonary Physiology

    • Pressures

      • Law of gases

      • PA (Alveolar Pressure)

      • PB (Barometric Pressure)

      • PIP (Intrapleural Pressure)

      • Inspiration versus expiration


    • Muscles of breathing

      • Inspiration

      • Expiration

      • Forced expiration

    • Surfactant functions

    • Elastic properties

      • Elastic recoil

      • Compliance

      • Resistance

    • Pulmonary functions

      • Ventilation

      • Diffusion

      • Perfusion

    • Gas transport

      • Oxygen transport

      • CO2 transport

    • Ventilation perfusion ratio

      • Shunting

      • Mismatched V/Q ratio

    • Normal breathing reference

      • Regular and comfortable at a rate of 12−20 breaths/min12-20\ \text{breaths/min}

      • Air trapping and other patterns may reflect specific pathophysiology


  • SigSigns and Symptoms of Pulmonary Disease

    • Dyspnea: subjective sensation of uncomfortable breathing

    • Orthopnea: dyspnea when a person is lying down


  • Abnormal Breathing Patterns

    • Tachypnea: rapid breathing; typically faster than 20 breaths/min

    • Hyperventilation: increased rate and depth of respiration (hyperpnea)

      • Kussmaul respirations: rapid, deep, labored breathing

    • Bradypnea: slower than 12 breaths/min

    • Hypoventilation: inadequate ventilation leading to elevated CO₂

    • Apnea: temporary cessation of breathing

    • Cheyne–Stokes respirations: alternating periods of deep and shallow breathing with apnea

    • Biot (ataxic) breathing: irregular pattern with varying depth and pauses


  • Signs: hypercapnia, hypoxemia, cyanosis, clubbing, and pulmonary edema

    • Cyanosis

    • Clubbing

  • Hypercapnia vs Hypocapnia

    • Hypercapnia: elevated arterial CO₂ partial pressure (PaCO₂)

    • Hypocapnia: reduced PaCO₂ (e.g., with hyperventilation)


  • Pulmonary Edema (fluid in lungs)

    • Gas exchange impairment due to excess fluid in interstitium/alveoli

    • Starling forces: pressures governing fluid movement

    • Key fluid movement schema (net filtration):

    • Filtration driven by capillary hydrostatic pressure vs interstitial hydrostatic pressure

    • Reabsorption driven by capillary oncotic pressure vs interstitial oncotic pressure

    • Lymphatics remove excess interstitial fluid

    • Diagrammatic/physiologic summary (simplified):

    • Capillary hydrostatic pressure (Pc) promotes filtration

    • Interstitial hydrostatic pressure (Pi) opposes filtration

    • Capillary oncotic pressure (pi_c) promotes reabsorption

    • Interstitial oncotic pressure (pi_i) promotes filtration


  • Atelectasis (collapse of lung tissue)

    • Absorption atelectasis: inspired air washes out by obstruction (e.g., mucus plug, closed pore of Kohn)

    • Compression atelectasis: external pressure (e.g., tumor) leads to collapse

    • Normal alveolus vs atelectatic alveolus: decreased inflation due to mucus plug or loss of air


  • Bronchiolitis and Bronchiolitis Obliterans

    • Bronchiolitis: inflammatory obstruction of small airways; common in children (RSV); can occur in adults with chronic bronchitis, viral infection, or inhalation of toxic gases

    • Bronchiolitis obliterans (Popcorn lung): late-stage fibrotic disease of airways from chronic inflammation; may occur with bronchiolitis, lung transplant, toxic exposures


  • Pleural Abnormalities

    • Pneumothorax: air in pleural space causing lung collapse

    • Open pneumothorax vs tension pneumothorax (one-way valve effect)

    • Pleural effusion: fluid in pleural space

      • Transudative effusion: due to hydrostatic/oncotic imbalance

      • Exudative effusion: due to inflammation/infection

    • Empyema: pus in pleural space

    • Hemothorax: blood in pleural space


  • Pneumothorax and Pleura visuals (descriptive)

    • Pneumothorax: outside air enters due to disruption of chest wall/parietal pleura or disruption of visceral pleura

    • . Tension pneumothorax: air entry with trapped air increases intrathoracic pressure, compressing mediastinum


  • Flail Chest: fractured ribs segment detaches from rest of chest wall

  • Smoking effects on lungs

    • Smoking decreases surfactant production, increasing risk of alveolar collapse and impaired compliance


  • Inhalation Disorders

    • Pneumoconiosis (e.g., silica, asbestos, coal) and exposure to toxic gases

    • Allergic alveolitis (hypersensitivity pneumonitis)


  • ARDS (Acute Respiratory Distress Syndrome)

    • Acute lung inflammation with diffuse alveolocapillary injury

    • Bilateral infiltrates on imaging; hypoxemia with decreased PaO₂/FiO₂ ratio

    • Common ICU complication with high mortality; causes include pneumonia, burns, aspiration, pancreatitis, transfusions, inhalation injury, sepsis/DIC


  • Pulmonary infections

    • Pneumonia: alveolar inflammation; community-acquired (e.g., Streptococcus pneumoniae), hospital-acquired pneumonia

      • Community-Acquired

      • Hospital Acquired

    • Pneumococcal pneumonia with lobar involvement (e.g., right upper lobe)

    • Tuberculosis: Mycobacterium tuberculosis; airborne transmission; tubercle formation; positive PPD test


  • Pulmonary Embolism

    • Occlusion of pulmonary arterial bed by thrombus or other embolus; commonly arises from deep veins in the legs


  • Pulmonary Hypertension-related disorders

    • Pulmo Cor Pulmonale: right ventricular enlargement/failure due to chronic pulmonary hypertension


  • Obstructive Lung Diseases

    • Asthma, Emphysema, Chronic Bronchitis as common obstructive disorders


  • Chronic Obstructive Pulmonary Diseases (COPD) phenotypes

    • Chronic bronchitis (blue bloater): chronic productive cough >3 months/year for 2 consecutive years; hypoxia, hypercapnia, polycythemia, cyanosis, digital clubbing; right heart failure risk

    • Emphysema (pink puffer): hyperinflation, CO₂ retention with less hypoxemia, pursed-lip breathing, dyspnea, barrel-shaped chest, and thin appearance


  • Pneumonia and related conditions

    • Pneumonia types: community-acquired (S. pneumoniae), nosocomial, viral

    • Lobar pneumonia examples and imaging


  • Key terms and connections

    • ARDS as a form of acute lung injury with alveolocapillary damage

    • Smoking and surfactant impairment contributing to COPD progression

    • Airway obstruction patterns in asthma and COPD

Cardio Pathology
  • Cardio Anatomy (major structures)

    • Heart chambers: right atrium, right ventricle, left atrium, left ventricle

    • Valves: tricuspid, mitral (AV valves); pulmonic and aortic (semilunar valves)

    • Major vessels: superior/inferior vena cava, aorta, pulmonary arteries/veins

    • Conduction system: SA node (pacemaker), AV node, Bundle of His, right/left bundle branches, Purkinje fibers

    • Coronary arteries: right coronary artery, left coronary artery with LAD and circumflex branches; collateral arteries

    • Pericardium: parietal and visceral layers, pericardial cavity with fluid; myocardium; endocardium

    • Layers

      • Tunica Intima/Endothelium

      • Tunica Media

      • Tunica Externa/Adventitia


  • Cardio Physiology basics

    • Cardiac cycle: diastole vs systole

      • Diastole

      • Systole

    • Valves and pressure changes during cycle

    • Mean arterial pressure (MAP) and cardiac output (CO) relationships


  • Cardiac Cycle & Pressures

    • Normal intracardiac pressures (mean and range):

    • Right atrium: mean 0-4 mmHg (typical mean ~4 mmHg) with range 0-8

    • Right ventricle: systolic ~24 mmHg (range 15-28); end-diastolic ~4 mmHg (0-8)

    • Left atrium: mean ~7 mmHg (range 4-12)

    • Left ventricle: systolic ~130 mmHg (range 90-140); end-diastolic ~7 mmHg (4-12)


  • Blood Pressure and Hemodynamics

    • BP = CO × PR (peripheral resistance)

    • Cardiac Output (CO) = Heart Rate (HR) × Stroke Volume (SV)

    • Regulation of BP involves: Autonomic nervous system (sympathetic/parasympathetic), baroreceptors, hormonal/humoral factors, local autoregulation (vasodilators/constrictors)

    • Factors affecting blood flow: pressure, resistance (vessel diameter/length), velocity, laminar vs turbulent flow, vascular compliance

    • Neural control centers: hypothalamus influences medullary centers; sympathetic vs vagal (parasympathetic) input to vessels and the heart


  • Cardiac Control and Autonomic Regulation

    • Sympathetic stimulation increases heart rate and contractility; vasoconstriction in arterioles (alpha) and vasodilation in skeletal muscle arterioles (beta midpoint)

    • Parasympathetic activity via the vagus nerve reduces heart rate


  • Cardiac Output determinants

    • Preload: LV end-diastolic volume (venous return)

    • Afterload: ventricular afterload to move blood (aortic pressure)

    • Contractility: inotropic state of the myocardium

    • End-diastolic volume and venous return influence preload; sympathetic activity affects contractility and afterload

    • Blood Volume


  • Conduction System Anatomy and ECG basics

    • Sinoatrial (SA) node as pacemaker

    • Atrioventricular (AV) node

    • Bundle of His

    • Right/left bundle branches

    • Purkinje fibers

    • Electrocardiogram (ECG) components: P wave (atrial depolarization), QRS complex (ventricular depolarization), T wave (ventricular repolarization)

      • Waves

      • Electrical events

      • Muscular Events

    • Intervals: PR interval, QRS duration, QT interval

    • Normal ECG expectations and rate calculations (Lead II common for rate)

    • Calculating EKG HR

      • Method 1 (300-150-100-75-60-50 method for regular rhythm: count large squares between R waves; 300 / number of large squares)

      • Method 2 (1500 method for regular rhythm: count small squares between R waves; 1500 / number of small squares)

      • Method 3 (6-second strip method for irregular rhythm: count QRS complexes in a 6-second strip and multiply by 10)


  • Heart Sounds

    • S1: closure of atrioventricular valves (tricuspid/mitral) at start of systole

    • S2: closure of semilunar valves (aortic/pulmonic) at end of systole

    • LUB DUB sequence


  • Vascular Homeostasis

    • Structures

      • Arteries

      • Arterioles

      • Capillaries

      • Venules

      • Veins

    • Resistance

      • Inner radius/diameter

      • Length

      • Turbulence vs Laminar flow

    • Venous Circulation


  • Hypertension and Vascular Pathology

    • Hypertension categories: normal, prehypertension, Stage 1 & Stage 2 hypertension, hypertensive crisis

    • Primary (essential) vs secondary hypertension; major risk factors include age, genetics, obesity/diabetes, smoking, hyperlipidemia, sedentary lifestyle

      • Primary

      • Secondary

      • Complicated hypertension: chronic hypertension that causes target organ damage

      • Malignant hypertension: severe, rapidly progressive hypertension with diastolic pressure often >140 mmHg, leading to organ damage (e.g., encephalopathy, retinal hemorrhages, renal failure)

    • Complications: target organ damage in heart, brain, vasculature, kidneys, eyes (often asymptomatic until damage)

    • Orthostatic hypotension: drop in BP on standing due to impaired compensatory mechanisms

    • Hypotension: abnormally low blood pressure


  • Vascular Disorders (overview)

    • Peripheral vascular disease (PVD) and peripheral arterial disease (PAD)

    • Arteriosclerosis vs atherosclerosis

    • Atherosclerosis progression: endothelial injury → fatty streak → formation of fibrous plaque → complicated lesion; mural thrombosis may form

    • Thromboangiitis obliterans (Buerger disease): inflammatory, nonatherosclerotic occlusions in small/medium arteries, often in young male smokers; autoimmune component

    • Raynaud phenomenon/disease: vasospastic disorder causing color changes in fingers/toes with cold or stress

    • Arteriosclerosis: thickening/hardening of arterial walls; loss of elasticity

    • Varicose Veins: distended, tortuous, palpable veins resulting from incompetent valves

    • Chronic venous insufficiency: inadequate venous return over a long period

    • Venous stasis ulcers: resulting from chronic venous insufficiency

    • Thrombus: a blood clot that forms in a vessel or heart chamber

      • Thromboembolisms: thrombus that has detached and is circulating in the bloodstream

      • Thrombophlebitis: inflammation of a vein wall associated with a thrombus

      • Deep venous thrombosis (DVT): thrombus in a deep vein, usually in the leg

        • Virchow’s Triad: three factors contributing to DVT formation (venous stasis, endothelial injury, hypercoagulable state)

    • Embolism: obstruction of a vessel by an embolus (e.g., blood clot, air, fat, foreign body)

    • Aneurysm: localized dilation or outpouching of a vessel wall or cardiac chamber

      • True aneurysm: involve all three layers of the arterial wall (e.g., fusiform, saccular)

      • False aneurysm (pseudoaneurysm): an extravascular hematoma that communicates with the intravascular space (e.g., due to trauma/leakage from vessel)

    • Cerebrovascular Disease (CVD): conditions that affect the blood supply to the brain, leading to stroke or transient ischemic attack (TIA)


  • Atherosclerosis details and disease progression

    • Damaged endothelium initiates a cascade leading to lipid accumulation and plaque formation

    • Plaques contain lipid pools, fibrous caps, and potential fissures; vulnerability to rupture leads to acute events (MI, stroke)

    • MODIFIABLE risk factors: dyslipidemia, hypertension, smoking, diabetes, obesity/sedentary lifestyle, atherogenic diet

    • NON-MODIFIABLE risk factors: age, gender, ethnicity, heredity

    • Clinical consequences: CAD, CVA, PAD


  • Cardiac Pathology: Pressure–Volume relationships and disease processes

    • Coronary artery disease (CAD): leading cause of myocardial infarction; atherosclerosis is primary etiologic factor

    • Angina: chest pain or discomfort due to reduced blood flow to the heart muscle (myocardial ischemia)

      • Stable angina: predictable chest pain on exertion, relieved by rest or nitroglycerin

      • Unstable angina: new onset, increasing severity/frequency, or occurring at rest; indicates high risk for MI

      • Prinzmetal angina (variant angina): unpredictable chest pain caused by coronary artery spasm

    • Ischemia: insufficient blood flow to meet metabolic demand

      • Silent ischemia: myocardial ischemia without chest pain or other symptoms

      • Transient ischemia: short-lived ischemia, often reversible, like TIA or stable angina

      • Sustained ischemia: prolonged ischemia, potentially leading to myocardial infarction

    • Angioplasty and stent placement; coronary artery bypass grafting (CABG) options (single, double, triple, quadruple grafts)

    • Disorders of the pericardium: acute pericarditis, constrictive pericarditis, pericardial effusion, tamponade

    • Disorders of the myocardium: dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy

    • Valvular dysfunctions: stenosis, regurgitation; mitral valve prolapse

    • Rheumatic heart disease: post-streptococcal immune-mediated valvular disease

    • Endocarditis: infection/inflammation of endocardium, often affecting valves; vegetations

    • Arrhythmias:

      • Tachycardia: abnormally fast heart rate (e.g., >100 bpm)

      • Bradycardia: abnormally slow heart rate (e.g., <60 bpm)

      • Flutter: rapid, regular atrial or ventricular contractions

      • Fibrillation: rapid, irregular, uncoordinated contractions (e.g., atrial fibrillation, ventricular fibrillation)

      • Premature Ventricular Contractions (PVCs)

      • Premature Arterial Contractions (PACs)

      • Asystole: absence of electrical or mechanical cardiac activity (flatline)

    • Heart failure: left-sided (systolic vs diastolic), right-sided; systemic venous congestion, pulmonary edema

      • Left Heart Failure

      • Right Heart Failure

    • Shock: cardiogenic, hypovolemic, neurogenic, anaphylactic, septic

      • Cardiogenic

      • Hypovolemic

      • Neurogenic

      • Anaphylactic

      • Septic

    • Multi Organ Dysfunction Syndrome (MODS): progressive dysfunction of two or more organ systems resulting from an uncontrolled inflammatory response to illness or injury

Hematologic Pathology
  • Blood composition and basic physiology

    • Blood volume: about 6 quarts (≈5.5 L)

    • Plasma: 90% water, 10% solutes; plasma proteins include albumins, globulins, fibrinogen

    • Formed elements: erythrocytes (RBCs), leukocytes (WBCs), thrombocytes (platelets)

    • Erythrocytes: primary oxygen transport; biconcave shape; lifespan ~120 days; produced via erythropoiesis stimulated by erythropoietin

    • Leukocytes: defense against infection; granulocytes (neutrophils, eosinophils, basophils) and agranulocytes (monocytes/macrophages, lymphocytes)

    • Platelets: essential for coagulation; thrombopoietin regulates production; circulate about 10 days


  • Hematopoiesis and bone marrow

    • Hematopoiesis: production of blood cells via mitosis and maturation/differentiation from multipotent pluripotent stem cells

    • Bone marrow: red (active) and yellow forms; major sites include pelvis, vertebrae, cranium, mandible, sternum, ribs, humerus, femur

    • MPS (mononuclear phagocyte system): monocytes/macrophages in tissues that ingest/destroy microbes and debris

    • Erythropoiesis sequence (simplified): pluripotent stem cell → common myeloid stem cell → erythroid progenitors (CFU-Eo, proerythroblast, normoblast, reticulocyte) → erythrocyte; regulated by erythropoietin from kidney


  • Hemoglobin and iron metabolism

    • Hemoglobin: Hb molecule contains heme groups and globin chains; each Hb can carry up to 4 O₂ molecules

    • Heme consists of iron-protoporphyrin complex; adult Hb typically α2β2 with 4 heme groups

    • Iron, vitamins, and minerals required for Hb synthesis: proteins/amino acids; vitamins B12, B6, B2, folic acid, pantothenic acid, niacin; minerals iron and copper

    • RBC turnover and bilirubin formation: aged RBCs phagocytosed by MPS; globin → amino acids; heme → bilirubin sent to liver and excreted in bile


  • Hematologic evaluation and pathologies

    • Anemias: classified by morphology and Hb content using MCV, MCH, MCHC

    • Macrocytic (large cells) - Normochromic or Normocytic: Pernicious anemia (B12 deficiency), Folate deficiency

    • Microcytic - Hypochromic: Iron deficiency anemia, Sideroblastic anemia, Thalassemia

    • Normocytic - Normochromic: Aplastic anemia, Posthemorrhagic, Hemolytic anemia, Sickle cell disease, Anemia of chronic inflammation

    • Pernicious anemia: B12 deficiency due to lack of intrinsic factor; neurologic manifestations possible; treatment with parenteral or high-dose B12

    • Folate deficiency anemia: lack of folate; absorption in small intestine; treatment with folate supplementation

    • Iron deficiency anemia: most common globally; glossitis and brittle nails; microcytic hypochromic anemia

    • Sideroblastic anemia: iron uptake/metabolism defect; ringed sideroblasts in bone marrow

    • Thalassemia: genetic disorder causing abnormal Hb synthesis; often Mediterranean origin; autosomal recessive

    • Sickle cell anemia: autosomal recessive; Hb S causes RBCs to sickle under hypoxia; crisis and vaso-occlusion

    • Polycythemia: overproduction of RBCs; absolute (PV) vs relative (dehydration)

    • Leukocytosis vs Leukopenia: common protective response vs risk of infection when low

    • Infectious mononucleosis: EBV infection; splenic rupture risk

    • Leukemias: ALL, AML, CML, CLL; acute vs chronic forms; Philadelphia chromosome in CML

    • Lymphadenopathy and Lymphomas: Hodgkin lymphoma (RS cells) vs Non-Hodgkin lymphomas

    • Coagulation disorders: vWF deficiency, vitamin K deficiency, liver disease causing broad hemostasis defects

    • Hemophilia A (factor VIII deficiency) and Hemophilia B (factor IX deficiency); X-linked recessive; variable severity

    • Disseminated Intravascular Coagulation (DIC): complex, fatal coagulation and bleeding; endothelial injury; FDP and D-dimer elevated


  • Hemostasis pathophysiology (coagulation cascade)

    • Primary steps of hemostasis:

      1) Vascular spasm (vasoconstriction) to reduce blood loss

      2) Platelet plug formation: adhesion via von Willebrand factor (vWF), activation, degranulation, aggregation, and stabilizing mesh formation

      3) Coagulation: coagulation cascades produce fibrin to form a stable clot

      4) Clot retraction and dissolution: platelets contracturing to pull wound edges; plasminogen activators convert plasmin to dissolve fibrin

    • Platelet activation requires Ca²⁺ and activation pathways (TXA₂, PGI₂ balance, GPIIb/IIIa receptor activation)

    • Coagulation cascades: Intrinsic, Extrinsic, and Common (classical) pathways culminating in the conversion of fibrinogen to fibrin by thrombin

    • Fibrinolysis: plasminogen → plasmin; plasmin degrades fibrin; D-dimers are fibrin degradation products


  • Practical and clinical connections

    • Understanding of hemodynamics (BP, MAP, CO, PR) helps interpret hypertension, shock, and heart failure dynamics

    • Dysfunctions in the coagulation system predispose to bleeding or thrombosis; DIC exemplifies a catastrophic combination of both

    • Knowledge of the conduction system and ECG basics is essential for recognizing arrhythmias and guiding therapy

    • Anemia classifications guide etiologic workup and treatment (iron vs B12/folate deficiency, anemia of chronic inflammation, hemolysis, etc.)

Key Formulas and Values (quick reference)
  • Blood pressure relationship:

    • BP=CO×PRBP = CO \times PR


  • Cardiac output:

    • CO=HR×SVCO = HR \times SV


  • Mean arterial pressure (MAP) approximation:

    • MAP=(2×diastolic)+systolic3MAP = \dfrac{(2 \times \text{diastolic}) + \text{systolic}}{3}


  • Normal respiratory rate (adults): 12≤RR≤20 breaths/min12 \leq\text{RR} \leq 20\ \text{breaths/min}

  • Hemodynamic/pressure relationships in the heart: reference intracardiac pressures (mean/typical ranges):

    • Right atrium: mean ~4 mmHg (range 0-8)

    • Right ventricle: systolic ~24 mmHg (range 15-28); end-diastolic ~4 (0-8)

    • Left atrium: ~7 mmHg (range 4-12)

    • Left ventricle: systolic ~130 mmHg (range 90-140); end-diastolic ~7 (4-12)


  • RBC and Hb basics

    • RBCs carry oxygen via hemoglobin with 4 heme groups per Hb molecule; each Hb can carry up to 4 O₂ molecules

    • RBC lifespan: about 120 days120\ \text{days}


  • Erythropoiesis regulation

    • Erythropoietin (from kidneys) stimulates RBC production in response to hypoxia

Connections to foundational principles
  • Homeostasis: Blood pressure, heart rate, and vascular resistance are tightly coordinated to maintain tissue perfusion; disturbances lead to hypertension, shock, ischemia

  • Gas exchange and acid-base balance: Pulmonary function (edema, atelectasis, ARDS) directly affects oxygenation and CO₂ removal; acid-base disturbances follow

  • Immunology and hematology integration: Leukocytes, lymphoid organs, and the hematopoietic system coordinate defense, immunity, and blood cell production; infections and malignancies disrupt these processes

  • Pathophysiology of chronic disease: Atherosclerosis, hypertension, COPD, and heart failure show how chronic processes (inflammation, remodeling, hypoxia) drive organ dysfunction over time

  • Ethical and practical implications: Early detection, monitoring, and management of chronic diseases impact quality of life, resource utilization, and long-term outcomes; recognizing asymptomatic hypertension or occult anemia is clinically important

Examples and scenarios (hypothetical)
  • A patient with progressive dyspnea, cyanosis, and edema may have congestive heart failure with reduced ejection fraction (systolic HF) or diastolic HF, requiring evaluation of preload/afterload and CO

  • A smoker presenting with chronic cough, dyspnea, wheeze, and barrel-shaped chest may have emphysema (pink puffer), whereas a patient with productive cough, cyanosis, and edema may have chronic bronchitis (blue bloater)

  • A patient with sudden chest pain and shortness of breath could have a pulmonary embolism or tension pneumothorax; quick recognition and management are critical to prevent collapse

  • Anemia workup includes differentiating macrocytic (B12/folate), microcytic (iron deficiency, sideroblastic, thalassemia), and normocytic etiologies to guide treatment

  • DIC represents a catastrophic failure of coagulation control, often in sepsis, where both thrombosis and bleeding occur concurrently; management focuses on treating the underlying cause and supportive care

References to common clinical entities (brief definitions)
  • ARDS: acute lung inflammation with diffuse alveolocapillary injury and hypoxemia despite oxygen therapy

  • COPD: umbrella term for chronic bronchitis and emphysema, leading to airflow limitation that's not fully reversible

  • TB: airborne infection with Mycobacterium tuberculosis; characteristic granulomas (tubercle formation)

  • Endocarditis: infection of the endocardial surface, often involving heart valves, with vegetations

  • Rheumatic heart disease: autoimmune valvular damage following group A streptococcal pharyngitis

  • Hypertension: sustained elevated arterial pressure; major risk factor for heart disease, stroke, kidney disease

  • Lymphomas/leukemias: clonal proliferations of lymphoid or myeloid cells; vary in aggressiveness and treatment approaches